How many investments has F-Prime Capital made?

F-Prime Capital has 434 tracked investments, 18 of which have exited via acquisition or IPO, including 6 dated in the last 24 months.

What stage does F-Prime Capital invest at?

F-Prime Capital invests at the Pre-Seed, Seed, Series A, Series B, Series C, Growth, Late Stage stages.

What is F-Prime Capital's typical check size?

F-Prime Capital typically writes checks of $3M – $10M.

Where is F-Prime Capital located?

F-Prime Capital is headquartered in Cambridge, US.

Does F-Prime Capital lead rounds?

Yes, F-Prime Capital leads investment rounds.

Who does F-Prime Capital co-invest with?

F-Prime Capital most often shares deals with ARCH Venture Partners, Eight Roads Ventures, GV (Google Ventures), among 651 tracked co-investors.

F-Prime Capital

Venture capital

Cambridge · Pre-Seed–Late Stage · 104 people tracked

Also known as F-Prime Capital Partners · IMPRESA MANAGEMENT LLC

★ Follow + Add to CRM ⤳ Find an introduction

✨ Fox Verdict

Investment thesis

F-Prime backs founders across healthcare and technology with a preference for early-stage investing, though it will support exceptional teams at any stage. In healthcare, it focuses on therapeutics, medtech, and healthtech plus services in a stage-agnostic manner. In technology, it targets enterprise software, fintech, frontier tech, and crypto. The firm draws on a legacy spanning more than 50 years and a team of scientists, engineers, physicians, operators, and investors who bring real-world expertise to help companies accelerate toward scalable growth.

Invests inBiotech Crypto & Web3 Deep Tech Digital Health Enterprise Software Fintech Healthtech Medical Devices SaaSSector AgnosticAsia-Pacific Boston Cambridge China Europe Global Mexico North America United States

Source: firm website, verified Aug 26, 2026.

Stage

Pre-Seed–Late Stage

Check

$3M – $10M

Cambridge, Massachusetts, US

Leads rounds

Leads

Instruments

Equity

Founded

2002

Last 12 months

4 investments

AUM

$13B

Tracked investments

439

Team · 104 people

from the firm's website & public directories

David Jegen· Managing Partner, Tech Fund· Cambridgein 𝕏

David Jegen is Managing Partner of F-Prime's Tech Fund, investing at the intersection of fintech and enterprise software, with led investments including Flywire, Toast, Snapdocs, and Kensho. He previously co-founded Sensoria, held roles at Cisco, J.P. Morgan, and BCG, co-founded the nonprofit Fintech Sandbox in 2015, and holds a Harvard Law degree plus economics and accounting degrees from Indiana University.

d•••@fprimecapital.comreveal

Alex Pasteur· Partner, PhD· Londonin

Alex Pasteur joined F-Prime in 2012 as a London-based Partner focused on therapeutics and life sciences investments. He was a founding investor in ARTBIO, Tenpoint Therapeutics and Orchard Therapeutics, and has worked in healthcare investing since 2001, previously at MVM Life Science Partners. He holds an M.A. in Natural Sciences and a PhD in Chemistry, both from Cambridge University.

a•••@fprimecapital.comreveal

Brett Cook· Partner· Cambridgein

Brett Cook is a Partner at F-Prime focused on healthcare technology and services investments, having led or participated in deals including Iora Health, PatientPing, 1up Health, Equip, NOCD, and Proximie. He rejoined F-Prime in 2018 after leading finance at PatientPing and working at Aledade and McKinsey; he holds an MBA from Harvard and a BSE in Biomedical Engineering from Duke.

Carl Byers· Partner· Cambridgein 𝕏

Carl Byers is a Partner with deep operating experience in healthcare IT. He was on the founding team of athenahealth, serving as CFO from 1997 to 2010, where he built the firm's financial systems, led multiple financing rounds, and drove its 2007 IPO. He previously consulted at Booz, Allen & Hamilton and teaches finance at Harvard's Chan School of Public Health.

c•••@fprimecapital.comreveal

Chong Xu· Partner· Cambridgein

Chong Xu is a Partner at F-Prime focused on biopharmaceutical and medical technology, and collaborates with the Eight Roads Ventures Asia team on portfolio and investment opportunities in China. He joined F-Prime in 2015 after roles at McKinsey, hedge funds Massif Partners and Affirmed Healthcare, and neurobiology research at Temasek Life Sciences Laboratory; he holds a PhD in Cell Biology and an MBA from the University of Virginia and a biology degree from Zhejiang University.

Gaurav Tuli· Partner· Boston, Massachusettsin

Jessica Alston· Partner· Boston, Massachusettsin

j•••@fprimecapital.comreveal

Jon Lim· Partner· Boston, Massachusettsin

Jon Lim is a Partner at F-Prime Capital Partners, where he leads venture and growth equity investments focused on healthtech and services companies through Fidelity's healthcare-focused venture fund.

j•••@fprimecapital.comreveal

Ketan Patel· Partner· Cambridge, Massachusettsin

k•••@fprimecapital.comreveal

M. Jackson Wilkinson· Venture and Operating Partnerin

Nihal Sinha· Partner· Londonin

n•••@fprimecapital.comreveal

Rocio Wu· Partnerin

Sachin Patodia· Partner

Sanjay Aggarwal· Partner· Cambridge, Massachusettsin

Sanjay Aggarwal is a Venture Partner at F-Prime Capital who invests in early-stage physical AI and enterprise AI companies. He also works with portfolio companies operating in the India-US corridor.

Bala Varadhan· Principal· Cambridgein

Principal at F-Prime focused on early-stage crypto, blockchain, and Web3 investments. Previously worked at Avon Ventures and BCG on private equity due diligence and growth strategy, with earlier roles in private equity and law. Holds an MBA from Kellogg, a JD from Pritzker School of Law, and dual B.A.s from UT Austin.

Ben Gorman· Principal· San Franciscoin 𝕏

Principal at F-Prime focused on early-stage investments in enterprise software and AI. Previously a managing consultant at IBM working on data- and ML-driven go-to-market transformation, and a Carnegie Mellon graduate in Statistics and Economics.

Betsy Mulé· Principal· San Franciscoin 𝕏

Principal at F-Prime focused on early-stage investments in enterprise technology and robotics. Previously a strategy consultant at Mars & Co. advising Fortune 500 companies across the US, Latin America and Europe. Holds a degree in Chemical-Biological Engineering from MIT.

Brian Yordy· Principal· Cambridgein

Brian Yordy joined F-Prime in 2018 and focuses on biopharmaceutical and medical technology investments. He previously was an engagement manager at McKinsey and Company advising pharma and medtech companies, and holds a PhD in immunology from Yale and a B.S. in biochemistry from Notre Dame.

Connie Li· Principal· San Franciscoin

Connie Li is a Principal on F-Prime's life sciences team focused on biotechnology investments, and collaborates with the Eight Roads Ventures China team on F-Prime's China investments. She joined F-Prime in 2019, was involved in forming companies including K36 Tx, Skyline, Pediatrix, and AlphaGen, and previously worked as a consultant at IQVIA advising biopharma companies. She holds an MBA and MS from Harvard and a BSE in Bioengineering from the University of Pennsylvania.

Hannah Arnold· Principal· Cambridge, Massachusettsin 𝕏

Kevin Chu· Principal· San Francisco, Californiain

k•••@fprimecapital.comreveal

Nikhil Marathe· Principal· Boston, Massachusetts, United Statesin

Nikhil Marathe is Principal and Head of Growth Equity at F-Prime, where he focuses on funding healthcare software and services businesses. He previously worked at Silversmith, TA Associates, and Evercore.

Allison MacLeod· Venture Partner· Cambridgein

Allison MacLeod is CMO of Flywire (Nasdaq: FLYW), where she leads global marketing and revenue operations and helped guide the company to its 2021 IPO. She has over 15 years of marketing experience, including roles at Rapid7 and Forrester, and advises early-stage companies.

Amber Cai· Venture Partner· Cambridge

Venture Partner at F-Prime focused on early-stage biotechnology investments, and founding CEO of gene and cell therapy company Skyline Therapeutics. She was previously a founding member and Head of Operations of Novartis' R&D Center in China, holds a PhD from MIT in GPCR signaling, and an MBA from MIT Sloan.

Bobby Gaspar· Venture Partner, MD, PhD· Londonin

A physician-scientist with over 25 years in medicine and biotechnology, Bobby Gaspar is a Venture Partner at F-Prime based in London. He is a scientific founder and CEO of Orchard Therapeutics, a pioneer in hematopoietic stem cell gene therapy, chair of Eligo Biosciences, and an honorary professor of pediatrics and immunology at UCL Great Ormond Street Institute of Child Health.

Carlos Bustamante· Venture Partner, PhD· San Francisco

Carlos Bustamante joined F-Prime in January 2019 as a Venture Partner in the San Francisco office, focusing on applying data science and genomics to problems in medicine, agriculture, and biology. He is on leave from Stanford University, where he is a Professor of Biomedical Data Science, Genetics, and Biology, and has founded and directed multiple academic units and companies. He holds a PhD in Biology and MS in Statistics from Harvard University.

Catherine Stehman-Breen· Venture Partner· Cambridge

Venture Partner at F-Prime based in the Cambridge office, focused on new company creation, with over 30 years of medical and biopharmaceutical experience. She previously served as CEO of Chroma Medicine, CRDO at Obsidian Therapeutics, EIR at Atlas Venture, and CMO at Sarepta Therapeutics, and holds an MD from the University of Chicago and an MS in epidemiology from the University of Washington.

Eric Blatte· Venture Partner· Cambridge

Eric Blatte joined F-Prime Capital as a Venture Partner in 2021, where he focuses on executive leadership and go-to-market functions in technology and cybersecurity companies. He has founded and helped lead companies from startup to over $100 million in revenue, including RiskRecon (acquired by Mastercard), Trusteer (acquired by IBM), Imprivata (IPO), and Centra Software (IPO). He holds an undergraduate degree from the Wharton School at the University of Pennsylvania and an MBA from MIT Sloan.

Gordon Chen· Venture Partner

Harlan Krumholz· Venture Partner

Jay Farber· Venture Partner· San Francisco, Californiain 𝕏

Jessica Chen· Venture Partner

John Vigeant· Venture Partner

Jon Gelsey· Venture Partner

Josh Feinblum· Venture Partner· Boston, Massachusettsin 𝕏

Julia McDowell· Venture Partnerin

Michael Zheng· Venture Partner

Mihir Shah· Venture Partner

Muz Mansuri· Venture Partner· Concord, Massachusetts, United Statesin

Namandjé N. Bumpus· Venture Partner

Nicholas Haining· Venture Partner

Richard Pazdur· Venture Partner

Sam Bisbee· Venture Partner· Boston, Massachusettsin 𝕏

Sam Bisbee serves as Vice President of Information Security at DraftKings Inc. He has held senior technology and cybersecurity roles across multinational enterprises, startups, and B2B SaaS companies, and provides advisory services to enterprise leaders, investors, and startups.

Sandor Palfy· Venture Partner· Budapest, Hungaryin 𝕏

Stephanie Robotham· Venture Partner

Steve Johnson· Venture Partner

Thomas Beck· In Memoriam

Miles Lasater· Venture Partner· San Francisco, Californiain

Miles Lasater is founder and CEO of Purpose Built, an investment and development firm. Through Purpose Built, he has launched Coral Care, Twill, and Sora Care, while maintaining an investment portfolio that includes Honor, Brightside Health, Remix, Notable Health, and Balto Software, alongside nonprofit investments in Issue One, One Acre, and MakeHaven. Previously, Lasater co-founded Higher One while in college, growing it to over $200 million in revenue and an IPO before founding SeeClickFix and OneUni. He hosts the "Startups for Good" podcast focused on mission-driven ventures and their founders.

Mona Vernon· Venture Partner· Boston, Massachusetts𝕏

Tristan Zajonc· Venture Partner· San Francisco, Californiain 𝕏

Tristan Zajonc is cofounder and CEO of Continual, an AI agent platform for business. Previously, he cofounded Sense, a data science and machine learning platform acquired by Cloudera in 2016, where he subsequently led the ML engineering team for three years. His earlier career included ten years in applied data science roles with organizations including USAID, the World Bank, and Harvard University's Institute for Quantitative Social Science, and he holds a PhD from Harvard University.

Abby Wagner· Senior Accountant· Cambridgein

Abby Wagner joined F-Prime Capital in September 2024 as a Senior Accountant. She previously worked as an Assurance Senior at Ernst & Young, LLP, focusing on private clients in the wealth and asset management industry. She holds an MBA and a BS in Accounting with a minor in Finance from Auburn University.

Abdul Abdirahman· Senior Associate· Boston, Massachusettsin 𝕏

Abdul Abdirahman is a Principal at F-Prime Capital, concentrating on early-stage B2B software and fintech investments. Before F-Prime, he invested in emerging markets technology startups and worked with a venture-backed digital banking and payments startup in East Africa. He started his career in financial services, providing assurance and valuation work for venture capital, private equity, and hedge funds in New York and London, and holds B.A. and B.S. degrees from the University of Minnesota along with joint MBA and MPA/ID degrees from Stanford's Graduate School of Business and the Harvard Kennedy School.

Allan Galper· Vice President & Associate General Counsel· Cambridge

Allan Galper serves as Vice President & Associate General Counsel at Fidelity Investments and supports F-Prime on legal matters spanning portfolio company investments and exits, fund formation, fund administration, and management company operations. He has over 25 years of legal experience across biotech, healthcare, software, and financial services, and previously was a partner at McCarter & English and an associate at Willkie Farr & Gallagher.

Andrew Bognanni· Director of Finance· Cambridge

Andrew Bognanni joined F-Prime in April 2022 to support the firm's finance and operations teams. He previously worked as a Manager at Standish Management and in the audit practice at RSM, and holds an M.S. in Accounting from Northeastern University.

Cathy Wong· Senior Director of Finance· Cambridgein

Cathy Wong joined F-Prime as Senior Director of Finance in July 2023, bringing over 14 years of accounting and finance experience. She previously served as a Controller at THL and held accounting and tax roles at Blackstone, Bain Capital, Bain & Company, and PwC. She holds a B.S. in Business Administration from Boston University and is a licensed CPA in Massachusetts.

Chance Mathisen· Associate· Cambridgein

Associate at F-Prime focused on early-stage enterprise software investments. Previously a consultant in Accenture's Software & Platforms Strategy practice, advising hyperscalers and technology companies on go-to-market and market expansion. Holds a B.S. in Managerial Economics from UC Davis.

Christine D'Attilio· Executive Assistant

Claire Knowlton· Marketing Associate· Cambridgein

Claire Knowlton joined F-Prime in 2025 as a Marketing Associate, supporting marketing through event planning and internal communications. She previously worked in email and social media marketing at an estate planning law firm and holds a BA in Marketing from Loyola University Chicago.

Clay Basser-Wall· Chief Compliance Officer· Cambridgein

Clay Basser-Wall is F-Prime's Chief Compliance Officer with over 20 years of legal and compliance experience. He joined F-Prime in 2020 after roles at Fidelity's Ethics Office, the U.S. SEC as an enforcement attorney, and law firms Wilson Sonsini and Brobeck Phleger & Harrison.

Crissy Derome· Executive Assistant· Cambridge

Crissy Derome joined F-Prime Capital in 2024, supporting the Crypto team, and serves as Project Coordinator for Fine Structure Ventures managing executive operations and scheduling. She previously held senior administrative roles at Fidelity Investments, Devonshire Investors, and Shields Health Care Group, and holds a Paralegal Studies degree from Eastern Nazarene College.

Davina Magargal· Head of Marketing· Cambridgein

Davina Magargal is F-Prime's Head of Marketing, overseeing brand strategy, communications, and marketing, with over 20 years in venture capital. She previously handled investor communications at Excel Venture Management and led marketing at Globespan Capital Partners and JAFCO Ventures, and holds a BA from Cedar Crest College.

Debbie Griffin· Chief Financial Officer· Cambridgein

Debbie Griffin is CFO at F-Prime with over 25 years of experience, overseeing finance and administration for Life Sciences and Fine Structure Ventures. She first joined F-Prime in 2013 for a decade in various finance roles, later served as CFO at Human Capital, and rejoined F-Prime in April 2026. She previously held accounting roles at Devonshire Investors, CFGI, and Ernst & Young.

Derrick Williams· Receptionist· Cambridgein

Derrick Williams is the Receptionist at F-Prime, joining in October 2018. He previously spent five years in security with Northeast Security and studied Computer Networking Operations at Gibbs College.

Eleni Russell· Senior Director of Finance· Cambridgein

Eleni Russell is Senior Director of Finance at F-Prime, which she joined in 2018, and has more than 15 years of experience in venture capital and private equity. She previously worked as an Accounting Manager at Fidelity Investments, overseeing venture capital and private equity entities within the Corporate Accounting group, and earlier as a senior accountant at TVM Capital. She holds a Bachelor of Science in Finance from Suffolk University.

Elizabeth Lamb· Executive Assistant· Cambridge

Elizabeth Lamb is an Executive Assistant at F-Prime Capital Partners, which she joined in July 2025 before moving into a full-time role in March 2026 supporting several members of the team. She previously held Executive Assistant positions at startups and pharmaceutical companies including Kura Oncology, GNS Healthcare, and Vertex, and spent 17 years in the Legal Department at Fidelity Investments. She earned an AS in Computer Programming and an AA in Liberal Arts from Keene State College.

Erica Lee· Principal· Cambridgein

Erica Lee is a Principal at F-Prime, where she focuses on investments in healthcare technology and services companies. She joined the firm in 2021 after working as an investment banking associate at Bank of America Merrill Lynch, advising on IPO and M&A transactions in healthcare IT. She holds a B.A. in Finance and International Business from Georgetown University.

Garth Rapeport· Entrepreneur-in-Residence

Grace Root· Director of Finance

Henry Trapnell· Director of Industry Networksin

Jack Neureuter· Senior Associatein

Jillian Enos· VP of Finance

Jingwei Li· Senior Associatein

John Shiver· Special Advisor

Joshua Gray· Vice President and Associate General Counselin

Karen Roaf· Director of Human Resources

Kendra Ryan· Director of Ecosystem Network

Kyle Fasulo· Finance Managerin

Laura Wysk· Executive Assistant

Liam Maniscalco· Associate

Lisa Robidoux· Senior Accountantin

Lucia Del Guerzo· Office Manager

Martin Taylor· Senior Associate· Londonin

Martin Taylor is a Principal at F-Prime Capital focused on company building and early-stage venture capital investment in biotechnology. He has served on the founding or operational teams of five portfolio companies and holds particular interest in oncology, cardiovascular, renal, metabolic, and rare disease therapeutics. He holds a First Class BA and MSci from the University of Cambridge and a PhD from the Cancer Research UK London Research Institute and UCL, with an academic background in molecular biology, biochemistry, biophysics, and genetics.

m•••@fprimecapital.comreveal

Megan Jenkins· Senior Director of Financein

Michelle Doerr· Director of Compliance and Riskin

Mike Feng· Head of Technology and Data Sciencein

Natasha Rodgers· Associate

Nicole Creighton· Human Resources Generalist

Nikhil Ananth· Associate· Boston, Massachusettsin 𝕏

Olivia Carlson· Senior Associatein

Rachel Feely-Kohl· Vice President, Community & Platform

Rachel Woolbert· Executive Assistant

Raj Basak· Senior Associatein

Renée Beccia· Chief Financial Officer

Robert Weisskoff· Partner· Massachusettsin

r•••@fprimecapital.comreveal

Rosanne Yang· Senior Legal Counselin

Rosy Howell· Executive Assistantin

Sarah Alvarez· Executive Assistant

Sarah Lamont· Investor· Boston, Massachusettsin 𝕏

Sarah Lamont is an investor at F-Prime focusing on early-stage fintech companies. She can be reached at slamont@fprimecapital.com.

Shervin Ghaemmaghami· Investor· Cambridge, Massachusettsin 𝕏

Stacie Weninger· Venture Partner· Massachusettsin

Stephen Knight· President and Managing Partner· Cambridge, Massachusettsin

Stephen Knight is a Yale-trained MD/MBA physician-investor with Bell Labs and NIH roots and biotech operating experience who co-founds platform companies and works with academics to spin out science.

s•••@fprimecapital.comreveal

Tenzin Jampa· Data Scientistin

Alex Wong· Associate· Boston, Massachusettsin

Mary Bevelock Pendergast· Advisor· Massachusettsin

Founder mafia

5 people who came through F-Prime Capital went on to found or lead other companies.

Wei LiAssociateFounded Quantxbio +1 Miles LasaterVenture PartnerFounded SeeClickFix +1 Bobby GasparVenture Partner, MD, PhDFounded Orchard Therapeutics Carlos BustamanteVenture Partner, PhDFounded Galatea Bio Nate FoxVenture Summer AssociateFounded Ribbon Health

What they invest in

from 248 of 439 portfolio companies

Healthtech ×116Biotech ×105Medical Devices ×59AI & Machine Learning ×54Digital Health ×51SaaS ×47Fintech ×43Enterprise Software ×35

HQs:United States×155India×11United Kingdom×7China×5Switzerland×3Japan×3

Who they back

founder profiles across 153 portfolio companies

42%

solo founders

65 of 153 mapped founding teams

47%

repeat founders

of 108 founders with career history

~4 yrs

old at investment

median across 35 dated deals

Founding team size:solo founder×652 founders×643 founders×144+ founders×10

Where their founders studiedfrom 99 founders with education data

Harvard University ×6Massachusetts Institute of Technology ×6University of California, Berkeley ×6Harvard Business School ×5Columbia University ×4The Wharton School ×4Northwestern University ×3Pontificia Universidad Católica de Chile ×3

Where their founders worked beforefrom 108 founders with career history

ConsenSys ×5IBM ×5Goldman Sachs ×4McKinsey & Company ×4Uber ×4MIT ×3Stanford University ×3Airbnb ×2

Accelerator rootsportfolio companies that came through a program

Y Combinator ×15 Techstars ×5

12 founders hold a PhD · 21 hold an MBA (of 99 with degree data)

Investments · 439 tracked

founders shown can be your intro path

By year:2026 · 3 2025 · 5 2024 · 9 2023 · 17 2022 · 4 2021 · 6 2020 · 6 2019 · 2 2018 · 4 2017 · 3 2016 · 3 2015 · 469 dated

Caribou Biosciencescariboubio.com in 𝕏NASDAQ: CRBUMar 2021

Caribou Biosciences is a clinical-stage biopharmaceutical company developing CRISPR genome-editing therapies, including off-the-shelf CAR-T cell therapies for hematologic malignancies and armored cell therapies using its Cas12a chRDNA platform.

BiotechMedical DevicesBerkeley, US

Jennifer Doudna(Co-founder)Rachel Haurwitz(President and Chief Executive Officer, Co-founder)Martin Jinek(Co-founder)Andrew May(Executive Officer)

BoardJenny Rooke(Director)

Board seatRobert Weisskoff· per SEC Form D

Co-investorsAliment Capital Avego BioScience Capital IA Seed Ventures Mission Bay Capital Mission Biocapital Pontifax AgTech +2 more

Neumora Therapeuticsneumoratx.com in 𝕏NASDAQ: NMRAJan 2023

Neumora is a clinical research company developing investigational medications, with a focus on conducting clinical trials to obtain regulatory approval and make treatments available to patients.

BiotechDeep TechDigital HealthMedical DevicesWatertown, US

Joshua Pinto(Executive Officer)Tamara Tompkins(Executive Officer)Kari Stefansson(Director)Maykin Ho(Director)Alaa Halawa(Director)

BoardKristina Burow(Director)in

Board seatStacie Weninger· per SEC Form D

Co-investorsARCH Venture Partners Catalio Capital Management, LP K2 HealthVentures Mercury Fund Premier Partners SoftBank Vision Fund +1 more

peerTransferNASDAQ: FLYWFeb 2020SEC filingmedium confidence

Boston, US

John Raguin(Director)Phillip Riese(Director)Matthew Harris(Director)Alex Finkelstein(Director)Pablo Ventura Aranguren(Director)Michael Massaro(Executive Officer, Director)

Board seatDavid Jegen· per SEC Form D · $171.1M raise · filed Feb 2020

Co-investorsKfund

ShouTi Inc.NASDAQ: GPCRJan 2022SEC filingmedium confidence

BiotechSouth San Francisco, US

Raymond Stevens(Director)Ramy Farid(Director)Jessica Lifton(Director)Ting Xie(Director)Daniel Auerbach(Director)Cuiping Gu(Director)

Board seatRobert Weisskoff· per SEC Form D · $7M raise · filed Jan 2022

Xilio Therapeuticsxiliotx.com inNASDAQ: XLOJan 2021

Xilio Therapeutics is a clinical-stage biotechnology company developing masked immuno-oncology therapies that use protein engineering to remain inactive until activated by tumor-specific proteases within the tumor microenvironment.

BiotechHealthtechWaltham, US

Rene Russo(Executive Officer, Director)inJoseph Farmer(Executive Officer)Timothy Clackson(Executive Officer)Paul Clancy(Director)Daniel Curran(Director)Nancy Hong(Director)

Board seatRobert Weisskoff· per SEC Form D

Co-investorsBain Capital Life Sciences Bay City Capital M Ventures MRL Ventures Fund RA Capital RiverVest Venture Partners +4 more

Aclaris Therapeuticsaclaristx.comNASDAQ: ACRS

Aclaris develops investigational monoclonal antibodies and small-molecule inhibitors targeting immune pathways for the treatment of atopic, autoimmune, and respiratory diseases.

BiotechHealthtechMedical DevicesWayne, US

Neal Walker(Executive Officer, Director)Kamil Ali-Jackson(Executive Officer)Stuart D. Shanler(Executive Officer)Joseph Monahan(Executive Officer)Hugh Davis(Executive Officer, Director)James Loerop(Executive Officer)

Co-investorsAisling Capital APERTURE Venture Partners Foresite Capital RA Capital Sofinnova Ventures Sofinnova Venture Partners +1 more

Adageneadagene.com inNASDAQ: ADAG

Adagene is a clinical-stage immunotherapy company that uses computational biology and artificial intelligence to discover and design therapeutic antibodies for cancer treatment.

AI & Machine LearningBiotech

Co-investorsEight Roads Ventures Toba Capital General Atlantic

Avalyn Pharma Incavalynpharma.com inNASDAQ: AVLNSep 2023 · $175M

Avalyn Pharma develops inhaled therapies for pulmonary fibrosis, using a nebulization approach that delivers treatment directly to the lungs to reduce the tolerability problems of existing oral therapies.

BiotechHealthtech

Lyn Baranowski(CEO)in

Co-investorsAndera Partners Catalio Capital Management, LP InVivium Capital Norwest Venture Partners RiverVest Venture Partners SR One Capital Management +7 more

Beam Therapeuticsbeamtx.com in 𝕏NASDAQ: BEAMNov 2018

Beam Therapeutics develops gene-editing medicines, particularly base editors and precision genome editing technologies, to create lifelong cures for patients with serious genetic diseases.

BiotechDeep TechMedical DevicesCambridge, US

David R. Liu(Founder and Inventor)J. Keith Joung(Founder and Inventor)Feng Zhang(Founder and Inventor)David R. Liu, Ph.D.(Founder and Inventor)J. Keith Joung, M.D., Ph.D.(Founder and Inventor)Feng Zhang, Ph.D.(Founder and Inventor)

Co-investorsARCH Venture Partners Dreamers VC Eight Roads Ventures Foresite Capital GV (Google Ventures)HongShan Capital Group +1 more

Bicara Therapeuticsbicara.com in 𝕏NASDAQ: BCAX

Co-investorsAisling Capital Eight Roads Ventures Foresite Capital Premji Invest RA Capital Red Tree Venture+1 more

Coherus Biosciencescoherus.com in 𝕏NASDAQ: CHRS

Coherus Oncology develops and commercializes immuno-oncology therapies, including the approved LOQTORZI, to treat patients with cancer.

BiotechHealthtechMedical DevicesRedwood City, US

Dennis M. Lanfear(Executive Officer, Director)Denny Lanfear(Founder)inAlan C. Herman(Executive Officer)Jean-Frederic Viret, Ph.D.(Executive Officer)Peter K. Watler, Ph.D.(Executive Officer)Barbara K Finck, M.D.(Executive Officer)

Co-investorsHEALTHCARE ROYALTY PARTNERS Sofinnova Ventures Venrock

Coinbasecoinbase.com in 𝕏Nasdaq: COIN

Coinbase is a cryptocurrency exchange platform that offers trading, custody, and financial services for cryptocurrencies, stocks, derivatives, and prediction markets to consumers, institutions, and developers.

Crypto & Web3FintechSan Francisco, US

Brian Armstrong(Co-founder & CEO)inFred Ehrsam(Co-founder)inEmilie Choi(President & COO)Alesia Haas(Chief Financial Officer)Paul Grewal(Chief Legal Officer & Secretary)Lawrence (L.J.) Brock(Chief People Officer)

Co-investors1confirmation A.Capital Ventures a16z crypto Acrew Capital Andreessen Horowitz Ansa Capital +53 more

Compass Therapeuticscompasstherapeutics.com in 𝕏NASDAQ: CMPX

Compass Therapeutics develops antibody-based therapies targeting the tumor microenvironment to treat cancer.

BiotechHealthtechCambridge, US

Schuetz Thomas(Executive Officer, Director)Errik Anderson(Executive Officer, Director)Steve Tregay(Director)

Co-investorsBioBrit Foresite Capital OrbiMed venBio Partners Vivo Capital

Cytek Biosciencescytekbio.com in 𝕏NASDAQ: CTKBOct 2020

Cytek Biosciences develops high-parametric analytical instruments and software that enable scientists at pharmaceutical companies, contract research organizations, and academic institutions to generate and analyze biological datasets.

BiotechDeep TechHardwareHealthtechMedical DevicesBellevue, US

Wenbin Jiang, Ph.D.(CEO and Chairman of the Board)Wenbin Jiang(Executive Officer, Director)Ming Yan, Ph.D.(Chief Technology Officer)Ming Yan(Executive Officer, Director)Jiecheng Zhang(Director)Allen Poirson(Director)

Co-investors3E Bioventures Capital Northern Light Venture Capital

Denali Therapeuticsdenalitherapeutics.comNASDAQ: DNLIFeb 2024

Denali Therapeutics develops therapeutics for neurodegenerative diseases.

BiotechHealthtechMedical DevicesSan Francisco, US

Marc Tessier-Lavigne(Director)Ryan Watts(Executive Officer, Director)Alexander O. Schuth(Executive Officer)Carole Ho(Executive Officer)Steve E. Krognes(Director)

BoardDavid P. Schenkein(Director)in

Co-investorsARCH Venture Partners EcoR1 Capital Foresite Capital GV (Google Ventures)

Insmedinsmed.com in 𝕏NASDAQ: INSM

Insmed is a biopharmaceutical company that provides grants and charitable funding to support healthcare provider education and patient care initiatives focused on nontuberculous mycobacterial lung disease, non-cystic fibrosis bronchiectasis, and other serious lung diseases.

BiotechDigital HealthHealthtechMedical Devices

Will LewisinGeoffrey Allanin

Co-investorsBessemer Venture Partners Foresite Capital OrbiMed Prospect Venture Partners NVIDIA

Pony AiNASDAQ: PONY

Precision BioSciencesprecisionbiosciences.com in 𝕏NASDAQ: DTIL

Precision BioSciences develops gene-editing medicines using its proprietary ARCUS genome editing platform, which employs sequence-specific nuclease enzymes to insert, remove, or repair DNA in living cells to treat hard-to-treat conditions including rare genetic diseases and hepatitis B (HBV).

BiotechDeep TechHealthtechDurham, US

JEFF SMITH(Executive Officer)DEREK JANTZ(Executive Officer, Director)MATTHEW KANE(Executive Officer, Director)Jeff Smith(Co-founder)Derek Jantz(Co-founder)TODD MELBY(Executive Officer)

Co-investorsage1 Aliment Capital Brace Pharma OCV Partners OUP (Osage University Partners)Pontifax AgTech +4 more

Prime Medicineprimemedicine.com in 𝕏NASDAQ: PRME

Prime Medicine develops one-time genetic therapies using Prime Editing, a gene editing technology developed in David R.

BiotechDeep TechHealthtechMedical Devices

Andrew Anzalone(Co-founder and Head of Platform)David Liu(Co-founder)Allan Reine(Chief Executive Officer)Mohammed Asmal(Chief Medical Officer)Ann Lee(Chief Technical Officer)Svetlana Makhni(Chief Financial Officer)

Co-investorsARCH Venture Partners GV (Google Ventures)Newpath Partners OUP (Osage University Partners)Samsara BioCapital

Rallybio, LLCrallybio.com in 𝕏NASDAQ: RLYB

Rallybio is a clinical-stage biotech company developing therapies for people with severe and rare diseases, with a pipeline focused on complement dysregulation and hematology.

BiotechHealthtechNew Haven, US

Steve Uden(Co-Founder & Chief Executive Officer)Stephen Uden(Founder)inMartin(Co-Founder & Chairman)Jon(Chief Financial Officer)

Co-investors5AM Ventures Canaan Partners Connecticut Innovations Mitsui Global Investment Solasta Ventures

Toasttoasttab.com inNYSE: TOST

Toast provides a restaurant management platform combining point-of-sale hardware (Flex POS, Toast Go 3 handheld) with software tools for online ordering, payroll, and other operations.

FintechFoodTechRetail TechSaaSBoston, US

Stephen Fredette(Executive Officer, Director, Promoter)Jonathan Grimm(Director, Promoter)inAman Narang(Director, Promoter)inChristopher Comparato(Executive Officer, Director)

BoardSteve Papa(Director, Promoter)

PartnerDavid Jegen· led

Co-investorsBessemer Venture Partners Evolution VC Partners Glynn Capital Management Mastry Riot Ventures Teamworthy Ventures +2 more

Unum Therapeuticscogentbio.com in 𝕏NASDAQ: COGT

Cogent Biosciences is a biotechnology company developing small molecule precision therapies for genetically driven diseases where the cause is linked to a specific genetic mutation.

BiotechDigital HealthHealthtechLongevityMedical DevicesCambridge, US

Charles Wilson(Executive Officer, Director)Christiana Stamoulis(Executive Officer)

BoardBen Auspitz(Director)Liam Ratcliffe(Director)Bruce Booth(Director)in

Co-investorsAtlas Venture

Eywa Pharmaeywapharma.sg✓ verified

Eywa Pharma develops and manufactures generic drugs across multiple therapeutic areas and dosage forms, including tablets, capsules, and oral suspensions, for patients and pharmacies.

Advanced ManufacturingBiotechHealthtechMedical DevicesSingapore, SG

BoardKetan Patel(Director)

Leyden Labsleydenlabs.com in✓ verified

Leyden Labs develops nasal sprays containing antibodies that target respiratory viruses such as influenza and COVID at the nasal mucosa to prevent initial infection and transmission.

BiotechDeep TechHealthtechLeiden, NL

Koenraad Wiedhaup(Founder & Chief Executive Officer)inRonald Brus(Founder & Chief Growth Officer)inJaap Goudsmit(Founding Scientist and Senior Advisor)inDinko Valerio(Founder and Chair of the Supervisory Board)Jintanat Ananworanich(Chief Medical Officer)Clarissa Koch(Chief Scientific Officer)

Co-investorsClavystBio GV (Google Ventures)Bluebird Ventures Casdin Capital European Innovation Council Fund European Investment Bank +5 more

1Uphealth1up.health in 𝕏Apr 2023

1upHealth provides a FHIR-first health data platform that helps health plans and payers acquire, manage, and exchange healthcare data, including automating prior authorization, member data access, and provider directories.

Data & InfrastructureDigital HealthHealthtechBoston, US

Ritwik Sahu(Executive Officer, Director)Ricky Sahu(Founder)inJoseph Gagnon(Director)

BoardVictor Echevarria(Director)inDavid Jegan(Director)T. Scott Law, Jr.(Director)

Board seatDavid Jegen· per SEC Form D

Co-investorsEniac Ventures Jackson Square Ventures Meridian Street Capital Sixth Street Social Leverage

Affinia Therapeuticsaffiniatx.com inOct 2025

Affinia Therapeutics develops genetically engineered adeno-associated virus (AAV) therapies for treating genetic diseases, focusing initially on cardiovascular and central nervous system conditions.

AI & Machine LearningBiotechDeep TechWaltham, US

Luc Vandenberghe(Director)Aaron Tward, M.D., Ph.D.(Scientific Co-Founder)Botond Roska, M.D., Ph.D.(Scientific Co-Founder)Luk Vandenberghe, Ph.D.(Scientific Co-Founder and Adviser, and Board Member)Rami Daoud(Executive Officer)Rick Modi(Chief Executive Officer, Board Member)

Board seatRobert Weisskoff· per SEC Form D

Co-investorsAtlas Venture EcoR1 Capital Eight Roads Ventures GV (Google Ventures)New Enterprise Associates (NEA)TCG Crossover +1 more

Amphora MedicalMay 2013

HealthtechMaple Grove, US

Tom Ressemann(Executive Officer, Director)

BoardMichael Liang(Director)Dan Sachs(Director)

Board seatRobert Weisskoff· per SEC Form D

Co-investorsBaird Capital HBM Healthcare Investments Longitude Capital

Antlia Bioscience, Inc.antliabio.com inJun 2026SEC filingmedium confidence

Antlia Bioscience develops long-acting therapeutics aimed at treating chronic cardiometabolic diseases.

BiotechEncinitas, US

Brian Laurence Johnson(Executive Officer, Director)Ankit Mahadevia(Executive Officer, Director)

BoardBen Auspitz(Director)Carlos Garcia Echeverria(Director)

Board seatMartin TaylorNihal Sinha· per SEC Form D · $20M raise · filed Jun 2026

Buoy Healthbuoyhealth.com in 𝕏Nov 2020

Buoy Health offers an AI-based symptom checker that asks users questions to help identify possible health issues and guides them toward appropriate care, products, or providers.

AI & Machine LearningDigital HealthHealthtechBoston, US

Andrew Le(Executive Officer, Director, Promoter)Andrew Le, MD(Founder)inAdam Lathram(Executive Officer, Director, Promoter)Jose Eduardo Reyes(Director)Nathanael Yu Ren(Director)

Board seatCarl Byers· per SEC Form D

Co-investorsEvolution VC Partners Torch Capital FundRx Humana Optum Ventures WR Hambrecht

CHARM Therapeuticscharmtx.com inApr 2023

CHARM is a biotech company developing a next-generation menin inhibitor for acute myeloid leukemia (AML), designed to address resistance seen with first-generation approaches.

AI & Machine LearningBiotechHealthtechLondon

Lakshyaditya Singh Aithani(Executive Officer, Director)

BoardRishi Gupta(Director)Muzammil Mansuri(Director)Gary Glick(Director)

Board seatMuz MansuriNihal Sinha· per SEC Form D

Co-investorsNew Enterprise Associates (NEA)OrbiMed SR One Capital Management Axial VC NVentures

Checkmate PharmaceuticalsAug 2019

Activating the immune system to recognize and destroy tumor cells.

BiotechCambridge, US

Art Krieg(Executive Officer, Director)Barry Labinger(Executive Officer, Director)Chuck Abdalian(Executive Officer)David Mauro(Executive Officer)Karen Brennan(Executive Officer)Charles Yon(Executive Officer)

Board seatRobert Weisskoff· per SEC Form D

Co-investorsSofinnova Ventures Longitude Capital Novo Holdings

Comanche Biopharmacomanchebiopharma.com inJan 2024 · $75M

Comanche Biopharma is a biopharmaceutical company developing an investigational siRNA medicine (CBP-4888) targeting a root cause of preterm preeclampsia in pregnant women.

BiotechFemTechHealthtechConcord, US

Mike Young(Founder)T Scott Johnson(Founder)inPaul Antinori(Executive Officer)Allison August(Executive Officer)Michael Young(Executive Officer)Thomas Scott Johnson(Executive Officer, Director)

Board seatMuz MansuriKetan Patel· per SEC Form D

Co-investorsAtlas Venture GV (Google Ventures)Broadview Ventures Lilly Asia Ventures New Enterprise Associates (NEA)

Embark Veterinary, Inc.Jul 2021SEC filingmedium confidence

Boston, US

Board seatCarl Byers· per SEC Form D · $75M raise · filed Jul 2021

Co-investorsFounder Collective Material

Ensomaensoma.comJan 2023 · $50M

Ensoma is a genomic medicine company developing a platform for in vivo engineering of hematopoietic stem cells (HSCs), combining an off-the-shelf delivery system with a gene engineering toolkit intended to treat diseases with a one-time treatment.

BiotechHealthtechMedical DevicesBoston, US

Board seatStephen Knight· per SEC Form D

Co-investors5AM Ventures Aju IB Invesment Corporation Catalio Capital Management, LP Delos Capital Solasta Ventures Alexandria +7 more

Generation Biogenerationbio.comFeb 2018SEC filingmedium confidence

BiotechCambridge, US

Geoff McDonoughy(Executive Officer, Director)Glenn Goddard(Executive Officer)Mark Angelino(Executive Officer)

BoardJason Rhodes(Director)inAnthony Quinn(Director)

Board seatCatherine Stehman-Breen· per SEC Form D · $100.4M raise · filed Mar 2018

Co-investorsAtlas Venture Foresite Capital Invus

Notabenenotabene.id in 𝕏Jun 2026

Notabene provides compliance and regulatory technology for crypto businesses and financial institutions, helping them meet regulatory requirements like the FATF Crypto Travel Rule through real-time screening, sanctions checks, and wallet identification.

Crypto & Web3CybersecurityEnterprise SoftwareFintechNew York City, US

Pelle Braendgaard(CEO/ Co-Founder)inAndres Junge(Founder)inAnia Lipinska(Founder)inAlice Nawfal(Founder)in

BoardMatthew Walsh(Director)Peter Johnson(Director)in

Board seatDavid Jegen· per SEC Form D

Co-investorsDigital Currency Group ParaFi Capital Signature Ventures Wintermute Y Combinator DRW Venture Capital +4 more

OneAdvisoryJul 2025

Miami, US

Robert Nance(Executive Officer, Director, Promoter)Madalyn Armijo(Director, Promoter)

BoardChris Downer(Director)inRafi Lurie(Director)

Board seatDavid Jegen· per SEC Form D

Co-investorsBrewer Lane Ventures Ritholtz Wealth Management

Parrot Technologies Inc / DEFeb 2024SEC filingmedium confidence

Walnut, US

Roberto Cebrian Flores(Executive Officer, Director)David Villarreal Ortiz(Executive Officer, Director)

Board seatDavid Jegen· per SEC Form D · $5M raise · filed Feb 2024

Rarecyterarecyte.comJul 2023

Seattle, US

Ronald Seubert(Executive Officer, Director, Promoter)Evan Castiglia(Executive Officer)Joseph Victor(Executive Officer, Director)Frank Witney(Director)Eric Kaldjian(Executive Officer)

BoardRobert Shepler(Director)in

Board seatRobert Weisskoff· per SEC Form D

Co-investors5AM Ventures Arboretum Ventures Sofinnova Ventures Telegraph Hill Partners

Real Estate Equity Exchangeunisonim.comMay 2018SEC filingmedium confidence

Unison Investment Management (UnisonIM) is a registered investment adviser that builds and manages institutional equity and credit strategies giving exposure to U.S. residential housing and home price appreciation.

FintechPropTechSan Francisco, US

Thomas Sponholtz(Founder, CEO & Chairman)John Martinez(Director)Edgar Green(Director)James Riccitelli(Executive Officer, Director)Douglas H. Lowrey(Director)Matthew O'Hara(Chief Investment Officer)

Board seatDavid Jegen· per SEC Form D · $40M raise · filed Jun 2018

Snapdocssnapdocs.com in 𝕏May 2021

Snapdocs automates the digital mortgage closing process by connecting lending, settlement, and secondary market teams.

AI & Machine LearningFintechLegalTechPropTechSaaSPortland, US

Aaron King(Founder/CEO)inMatt Schindel(Executive Officer)Sanam Pangali(Executive Officer)

BoardAndrew Reed(Director)inAnu Hariharan(Director)

Board seatDavid Jegen· per SEC Form D

Co-investors137 Ventures Accelerator Ventures Alkeon Innovation MetaProp MetaProp Ventures Red Swan Ventures +9 more

Tempest Therapeuticstempesttx.comFeb 2020

Tempest Therapeutics is a clinical-stage biotechnology company developing in vivo CAR-T cell therapies for autoimmune and oncology indications.

BiotechHealthtechBrisbane, US

Stephen Brady(Director)Matthew Angel(Executive Officer, Director)Nicholas Maestas(Executive Officer)Thomas Woiwode(Director)Geoffrey Nichol(Director)Thomas W. Dubensky(Executive Officer, Director)

Board seatRobert Weisskoff· per SEC Form D

Co-investorsLAV Lilly Asia Ventures New Enterprise Associates (NEA)Quan Capital Roche Venture Fund

Threat Stackthreatstack.com inSep 2017

CybersecurityBoston, US

Jennifer M. Andre(Executive Officer)Dustin Webber(Director)Brian Ahern(Executive Officer, Director)Doug Cahill(Executive Officer, Director)

BoardChristopher P. Lynch(Director)Maria Cirino(Director)

Board seatGaurav Tuli· per SEC Form D

Co-investors.406 Ventures fama Ventures, LLC Techstars Accomplice Eight Roads Ventures Scale Venture Partners

Tradiertradier.com inApr 2023 · $24.6M

Tradier offers REST-based APIs and trading platforms providing equity, options, and futures trading, account management, market data, and brokerage services for individual developers and businesses.

FintechSaaSCharlotte, US

Dan Raju(Executive Officer, Director)inPeter Laptewicz(Executive Officer, Director)inRobert Kopple(Director)

BoardAlec Petro(Director)

Board seatDavid Jegen· per SEC Form D

Co-investorsDevonshire Investors

Tripsuitetripsuite.comSep 2024

TripSuite is a software platform for travel agencies that combines CRM, commission tracking, accounting, itinerary management, analytics, and workflow automation in one system.

SaaSTravel & HospitalityBrooklyn, US

Jacey Jones(Executive Officer, Director, Promoter)Christopher John Graves(Executive Officer, Director, Promoter)

Board seatGaurav Tuli· per SEC Form D

Viewrayviewray.com in 𝕏Dec 2014

ViewRay develops MRIdian A3i, an MRI-guided radiation therapy system that uses diagnostic-quality MRI imaging for real-time tissue tracking and automated beam control during cancer treatment.

HardwareHealthtechMedical DevicesOakwood Village, US

James F. Dempsey(Executive Officer, Director)James Dempsey(Secretary of the Issuer.)David Chandler(Mr. Chandler is the Chief Financial Officer of the Issuer.)Chris A. Raanes(Executive Officer, Director)Michael Brandt(Executive Officer)D. David Chandler(Executive Officer)

Board seatRobert Weisskoff· per SEC Form D

Co-investorsAisling Capital OrbiMed

Zenflowzenflow.com in 𝕏Nov 2024

Zenflow develops medical devices for treating benign prostatic hyperplasia (BPH) in men, founded from the Stanford Byers Center for Biodesign with a team experienced in medical device development and FDA regulation.

HealthtechMedical DevicesSan Francisco, US

Shreya Mehta(Founder/CTO)inNick Damiano(Executive Officer, Director)John Beck(Executive Officer)

BoardBryan Kim(Director)Blayne Roeder(Director)

Board seatRobert Weisskoff· per SEC Form D

Co-investorsAstia ShangBay Capital LLC Y Combinator Dorm Room Golden Seeds Medical Technology Venture Partners

Zus Healthzushealth.com in 𝕏Mar 2023SEC filingmedium confidence

Zus provides a platform that removes data waste in healthcare, enabling developers, clinicians, and operators to innovate in patient and care team experience without building underlying infrastructure.

Cloud ComputingData & InfrastructureDigital HealthHealthtechWatertown, US

Jonathan Bush(CEO)inTravis Smith(Executive Officer)

BoardSteven Fisher(Director)Fay Rotenberg(Director)Julie Yoo(Director)inBenjamin Silver(Director)

Board seatCarl Byers· per SEC Form D · $40M raise · filed Mar 2023

Co-investorsAdvection Growth Capital Andreessen Horowitz JAZZ Venture Partners Martin Ventures Maverick Ventures

1Money1moneynetwork.com in 𝕏

1Money builds a decentralized payment network for stablecoin and tokenized deposit transfers, designed for global financial settlements.

Crypto & Web3Fintech

Matt Shroder(Founder)Brian Shroder(Founder)in

Co-investorsA100X Ventures CMT Digital Ventures Ethereal Ventures Management Ltd.Generative Ventures Hack VC Protagonist +2 more

3F Labs

4118

66 Nao

Abelian Therapeutics

Abk Biomedical Incabkbiomedical.com in 𝕏

ABK Biomedical is a clinical-stage medical device company that develops x-ray visible glass microspheres for Y-90 radioembolization and embolic treatment of cancers such as liver cancer.

BiotechHealthtechMedical DevicesHalifax, CA

Bob Abraham(Executive Officer, Director)Robert Abraham(Co-founder (Interventional Radiologist, MD))Daniel Boyd(Co-founder (Material Scientist))Sharon Kehoe(Co-founder (Material Scientist))Anthony Headley(Executive Officer)Gary Donofrio(Executive Officer)

Co-investorsEight Roads Ventures Vivo Capital

Acacia Pharmaeagleus.com

Eagle Pharmaceuticals discovers, develops, and markets medicines for patients, healthcare providers, and health systems.

BiotechHealthtech

Co-investorsGilde Healthcare

Accuri Cytometers

Co-investorsArboretum Ventures

Adaptimmuneadaptimmune.com in 𝕏

Adaptimmune Therapeutics is a biotechnology company, though the specific focus of their therapeutic work is not detailed on this investors and media page.

BiotechHealthtechMedical Devices

Co-investorsAvoro Capital Advisors Eight Roads Ventures New Enterprise Associates (NEA)Ridgeback Capital

Adcentrx Therapeuticsadcentrx.com inApr 2023

Adcentrx Therapeutics is a biotech company focused on the discovery and clinical development of antibody-drug conjugates (ADCs) for oncology.

BiotechHealthtech

Hui Li(Founder, President & CEO)in

Co-investorsEight Roads Ventures Quan Capital Delta Capital

Adelabioadelabio.com in 𝕏

Adela develops blood-based diagnostic tests that analyze cell-free DNA using whole methylome analysis to detect and monitor cancer.

BiotechDigital HealthHealthtechFoster City, US

Daniel Diniz De Carvalho(Executive Officer, Promoter)Scott Bratman(Executive Officer, Director)Anne-Renee Hartman(Founder)Alan Williams(Executive Officer)Lisa Alderson(Executive Officer, Director)Priscilla Huang(Executive Officer)

Co-investorsDecheng Capital OrbiMed Deerfield Management Company Menlo Ventures

Aera Therapeuticsaeratx.com in 𝕏

Aera Therapeutics develops genetic medicines using next-generation delivery technologies and precision payloads optimized for specific diseases.

AI & Machine LearningBiotechDeep TechMedical DevicesCambridge, US

Feng Zhang, Ph.D.(Scientific Founder & Board Observer)Akin Akinc, Ph.D.(Chief Executive Officer & Board Director)

Co-investorsARCH Venture Partners Lux Capital GV (Google Ventures)JDRF T1D Fund Newpath Partners

AI biotechowkin.com in 𝕏

Owkin develops AI Scientist, an autonomous AI system that uses biological large language models and multimodal patient data to accelerate drug discovery for pharmaceutical and biotech companies.

AI & Machine LearningBiotechDeep TechDigital HealthHealthtechSilicon Valley, FR

Thomas Clozel(Co-Founder and Chief Executive Officer)inGilles Wainrib(Co-Founder and Former Chief Scientific Officer)in

Co-investorsBridford Investments (Bridford Group)Cathay Innovation Frst GV (Google Ventures)Alpha Intelligence Capital OTB Ventures +1 more

Airespace

Co-investorsNorwest Venture Partners Storm Ventures

Albert Inventalbertinvent.com in

Albert provides an operating system for chemists that combines structured data management with AI trained on molecular structures and individual company chemistry datasets.

AI & Machine LearningDeep TechEnterprise Software

Zach Kisner(Co-founder)inKen Kisner(Co-founder)inNick Talken(Co-founder)inNeelesh Vaikhary(Co-founder)inZack Kisner(Founder)

Co-investorsCapitalG Coatue Management Coral Capital Homebrew Index Ventures General Atlantic

Alderaskalder.com in

Alder provides geriatric care management for families navigating aging, pairing them with registered social workers and nurses who assist with medical appointments, care planning, and family decisions.

HealthtechLongevityWellness & FitnessBoston, US

Alfredalfredpay.io in 𝕏

Alfred Pay provides cross-border payment infrastructure for Latin America, offering virtual local bank accounts, instant multi-currency settlement, and a developer API.

Crypto & Web3FintechSaaS

Diego Yanez(Founder)in

Co-investorsDepartment of XYZ Digital Currency Group Rayo Capital Group Venture Dept.White Star Capital

Alibaba

Alibaba (Linkalibaba.com

Alibaba.com operates a global B2B e-commerce marketplace that connects buyers with suppliers and manufacturers for wholesale products across multiple industries.

AI & Machine LearningB2B MarketplacesE-commerce

Co-investorsAcross Capital Partners Granite Asia ICONIQ K2 Global Lead Edge Capital Mosaic Ventures +3 more

Alluvial

Alluvial Financealluvial.financeAcquired

Staking software developer behind the enterprise liquid staking protocol Liquid Collective, acquired by Galaxy Digital in December 2025.

Chicago, US

Matthew R. Leisinger(Executive Officer, Director)Mara Schmiedt(Executive Officer, Director)Evan Weiss(Executive Officer)

BoardMin Teo(Director)

Co-investorsAmbush Capital Coinbase Ventures Fenbushi Capital Figment Nascent Variant Fund

Almanac Healthalmanac.chat in 𝕏

Almanac Health is a clinical AI company that builds Almanac Chat, an evidence-based platform for clinical AI use by clinicians and health systems.

AI & Machine LearningDigital HealthHealthtechDover, US

Cyril Zakka(Executive Officer, Director)

Co-investorsGeneral Catalyst Lightspeed Venture Partners

Alphagen Therapeuticsalphagentx.com

Co-investorsEight Roads Ventures

AlphaGen Tx

Alternative Bio Abioabio-x.com in 𝕏

ABio-X is an incubation platform that creates life sciences companies by combining new technologies with scientific research to develop drug candidates for large, historically difficult diseases.

BiotechDeep TechHealthtech

Amber Therapeuticsamber-tx.com in

Amber Therapeutics develops medical technology focused on treating mixed urinary incontinence, advancing toward pivotal clinical trials in the US with expanded feasibility studies in Europe.

Medical Devices

Co-investorsIntuitive Ventures Lightstone Ventures New Enterprise Associates (NEA)Oxford Science Enterprises

AmplifyMDamplifymd.com in

AmplifyMD offers a virtual care platform with EHR integrations, automation, embedded AI tools, and a network of remote specialists that lets hospitals and health systems expand physician capacity and add specialty services.

AI & Machine LearningDigital HealthEnterprise SoftwareHealthtechSaaSLos Gatos, US

Anand Nathan(Co-Founder & Chief Product Officer)inMeena Mallipeddi(Co-Founder & Chief Executive Officer)inMohan Mallipeddi, MD(Chief Medical Officer)inNijay Patel(Chief Technology Officer)inKurt Blasena(Chief Commercial Officer)in

BoardStephen K. Klasko(Board of Directors)

Co-investorsForerunner Ventures Greylock Partners Tau Ventures TAU Ventures

Apellisapellis.com in 𝕏

Co-investorsAvoro Capital Advisors Epidarex Capital Keyhorse Capital Sofinnova Ventures Solasta Ventures venBio Partners

Appellis

AppliedVRappliedvr.io in 𝕏

AppliedVR develops immersive therapeutic software using technology to deliver drug-free clinical treatments for patients.

Digital HealthHealthtechMedical DevicesLos Angeles, US

Matthew Stoudt(Co-Founder and CEO)inJosh Sackman(Co-Founder and President)in

BoardDavid Sackman(Chairman)

Co-investorsEntrada Ventures JAZZ Venture Partners Magnetic Ventures Presence Capital Techstars

AppsFlyerappsflyer.com in 𝕏

AppsFlyer provides a marketing measurement and attribution platform that collects validated, fraud-filtered signals across app, web, CTV, PC, and console to feed AI-driven marketing decisions.

AdTechData & InfrastructureMarketing Tech

Oren Kaniel(Founder)inReshef Mann(Founder)in

Co-investors10D DTCP Eight Roads Ventures Meta Pitango Qumra Capital +1 more

Apreo Healthapreohealth.com in

Apreo Health develops a bronchoscopic treatment for severe emphysema using a self-expanding airway scaffold designed to reduce trapped air and improve lung function.

BiotechHealthtechMedical DevicesMenlo Park, US

Karun Durgam Naga(Executive Officer, Director)

BoardHanson S. Gifford III(Director)Zack Scott(Director)Michael A. Carusi(Director)Drew Field(Director)Dennis McWilliams(Director)

Co-investorsIntuitive Ventures Lightstone Ventures Norwest Venture Partners

Argyleargyle.com in 𝕏Jan 2022

Argyle provides a verification platform that automates the collection and verification of income, employment, and asset data using consumer-permissioned, real-time data from payroll, banking, and document sources.

Data & InfrastructureFintechNew York, US

Samuel Fishman(Executive Officer, Director, Promoter)Shmulik Fishman(Founder)inDaniel Yanisse(Director)Christopher Hansen(Executive Officer, Director)

Co-investorsRackhouse Venture Management Lp SignalFire Bain Capital Ventures Socially Financed Socii Capital

Arion Cancer Hospitalarioncare.cn

Arion Care (美中爱瑞) is an oncology-focused hospital in China providing cancer diagnosis and treatment through multidisciplinary team (MDT) consultations and specialized centers for lung, breast, gastrointestinal, gynecologic, urologic, hepatobiliary, lymphoma, neurologic, and other cancers.

Digital HealthHealthtech

Arnatar Therapeuticsarnatar.com in 𝕏

Arnatar develops RNA therapeutics using its DARGER platform, which combines gene silencing via siRNA with protein upregulation through antisense oligonucleotides (ACT-UP1).

BiotechDeep Tech

Co-investors3E Bioventures Capital Apricot Capital Eight Roads Ventures Gaorong Ventures Legend Star New Alliance Capital

ARTBIO

Develops alpha radioligand therapies (ARTs) for targeted cancer treatment with a resilient supply chain.

Co-investorsB Capital Group

Artemis Healthartemishealth.com in 𝕏Feb 2019

Artemis Health provides data analytics and insights software to U.S. employers, advisors, and payers to optimize health benefits and reduce healthcare costs.

Data & InfrastructureEnterprise SoftwareHealthtechSalt Lake City, US

Grant Gordon(Executive Officer, Director)inDallen Allred(Executive Officer, Director)Dallin Regehr(Executive Officer)Dallin Preston Regehr(Executive Officer, Director)

BoardDalton Wright(Director)inJon Lim(Director)in

Co-investorsBessemer Venture Partners Kickstart Valence Ventures Maverick Ventures

Arvelle Therapeuticsangelinipharma.ch in

Angelini Pharma Switzerland is the Swiss arm of a pharmaceutical company focused on brain health and epilepsy, offering prescription treatments for patients and healthcare professionals.

BiotechConsumerHealthtechZug, CH

Co-investorsAndera Partners H.I.G. Capital H.I.G. HealthBridge Partners

Ashbyashbyhq.com in 𝕏

Ashby is a recruiting software platform that serves as an applicant tracking system (ATS) and all-in-one hiring management tool for talent teams.

Enterprise SoftwareHR TechSaaSSan Francisco, US

Benjamin Encz(Founder)inAbhik Pramanik(Co-Founder & VP of Engineering)in

Co-investorsAlkeon Innovation DVC SemperVirens Venture Capital Todd and Rahul’s Angel Fund Trail Run Capital Y Combinator +1 more

Astraeus

Asymmetry Financeasymmetry.finance 𝕏

Asymmetry Finance is a decentralized finance protocol that lets users borrow stablecoins (USDaf and AmpUSD) against BTC or stablecoin collateral at customizable fixed interest rates.

Crypto & Web3Fintech

Co-investorsMagnus Capital Silvermine Capital Avon Ventures Castle Island Ventures Ecco Capital gmjp +1 more

Atalantaatalanta.tech in 𝕏Jan 2025 · $97M

Atalanta is a mathematical AI company that provides software verification and formal methods capabilities to ensure provably correct decision-making in complex systems for high-stakes missions in energy, space, and defense sectors.

AI & Machine LearningDeep TechDefense Tech

Jonathan Ring(Founder)in

Co-investorsFelicis Ventures abrdn plc EQT Life Sciences

Atalantaatalantatx.com in 𝕏

Atalanta develops RNA interference-based therapeutics aimed at treating central nervous system and neurological diseases.

BiotechHealthtech

Co-investorsNovartis Venture Fund RiverVest Venture Partners Sanofi Ventures abrdn plc EQT Life Sciences

Avalyn Pharmaceuticals

AvantStayavantstay.com in 𝕏

AvantStay operates a collection of fully furnished, design-forward vacation rental homes in sought-after U.S. destinations, offering short- and long-term stays with amenities like concierge service, Wi-Fi, and smart locks.

B2B MarketplacesFuture of WorkMarketplacesPropTechTravel & HospitalityCulver City, US

Sean Breuner(Executive Officer, Director, Promoter)Reuben Doetsch(Executive Officer, Director, Promoter)Jesse Suarez(Executive Officer)Jodi Kessler(Director)

BoardShawn Colo(Director)Eric Wiesen(Director)in

Co-investorsAbstract Ventures Blue Ivy Ventures Bullpen Capital Convivialité Ventures Daft Capital Evolution VC Partners +5 more

AvenCellavencell.com in 𝕏

AvenCell Therapeutics develops next-generation cell therapies for hard-to-treat cancers, including solid tumors, combining switchable universal CAR-T technology with a CRISPR/Cas9-based allogeneic platform.

BiotechLongevityMedical Devices

Andrew Schiermeier(Chief Executive Officer)in

Co-investorsNovo Holdings Blackstone Life Sciences Eight Roads Ventures NYBC Ventures

Aviadobio

Gene therapy company developing transformative medicines for neurodegenerative disorders.

Co-investorsLifeArc Ventures

AviadoBio Websiteaviadobio.com in 𝕏

AviadoBio is a gene therapy company developing adeno-associated viral (AAV) treatments for neurodegenerative disorders such as amyotrophic lateral sclerosis (ALS) and frontotemporal dementia (FTD).

BiotechDeep TechDigital HealthHealthtech

Chris Shaw(Co-Founder & Chief Scientific and Clinical Advisor)Do Young Lee(Co-Founder)Youn Bok Lee(Co-Founder)Lisa Deschamps(Chief Executive Officer)Graeme Fielder(Chief Operating Officer)Alex Bloom(Chief Development Officer)

Co-investorsAdvent Life Sciences Dementia Discovery LifeArc Ventures Monograph Capital Partners New Enterprise Associates (NEA)

Avidity Nanomedicinesaviditybiosciences.com in

Avidity Biosciences develops Antibody Oligonucleotide Conjugates (AOCs) that combine monoclonal antibody specificity with oligonucleotide precision for targeted delivery of RNA therapeutics to treat rare genetic muscle diseases.

BiotechDeep TechHealthtechMedical Devices

Co-investorsAvoro Capital Advisors Brace Pharma Frazier Life Sciences Moore Venture Partners

Avivomedavivomed.com

Avivomed is a medical device company developing minimally invasive neuromodulation therapies for patients with obstructive sleep apnea.

BiotechDeep TechHealthtechMedical DevicesRoseville, US

Lynn Elliott(Co-Founder)Mudit Jain(Co-Founder)Paul Mazanec(Chief Executive Officer)Stephen Masson(Executive Officer, Director)

BoardTheresa C. Pappas(Director)Ketan Patel(Director)in

Co-investorsHatteras Venture Partners Treo Ventures, Llc

Axle Healthaxlehealth.com in 𝕏

Axle Health provides a logistics and scheduling platform for home health care providers that optimizes clinician routing, staffing decisions, and patient coordination through real-time data and predictive forecasting.

AI & Machine LearningDigital HealthHealthtechLogistics & Supply ChainSaaSLos Angeles, US

Adam Stansell(Founder)in

Co-investorsRebel Fund TRAC (Third Round Analytics Capital)Y Combinator

B One Orthob1.co

Co-investorsEight Roads Ventures

Bang Er Medical

Beadsbeads-hospice.jp

Beads Hospice operates a residential facility in Japan that provides palliative and end-of-life care for patients with terminal cancer, neurodegenerative diseases, and other specified conditions.

Digital HealthHealthtechLongevityWellness & Fitness福岡市, JP

Co-investorsEight Roads Ventures

Benchlingbenchling.com in 𝕏Apr 2016

Benchling provides a cloud-based R&D platform for life sciences, combining a collaborative electronic lab notebook, structured scientific data modeling, automated workflows, and AI tools.

AI & Machine LearningBiotechEnterprise SoftwareSaaSSan Francisco, US

Sajith Wickramasekara(Founder/CEO)inAshutosh Singhal(Director)Ashu Singhal(Founder)in

BoardMiles Grimshaw(Director)in

Co-investorsAlkeon Innovation Andreessen Horowitz Artisanal Ventures Balaji Srinivasan Draper Associates ICONIQ +12 more

Benchscibenchsci.com in 𝕏

BenchSci provides a proprietary knowledge graph and curated biomedical dataset built from millions of research papers, patents, preprints, and databases, covering reagents such as antibodies, RNAi, CRISPR records, cell lines, and animal models.

AI & Machine LearningBiotechData & Infrastructure

David Qixiang Chen, PhD(Founder)inElvis WiandaLiran Belenzon

Co-investors500 Global Afore Capital Creative Destruction Lab (CDL)FounderFuel Golden Venture Partners Golden Ventures +2 more

Better Life Medicalgoblm.com.cn

Co-investorsEight Roads Ventures

Better Life Partnersbetterlifepartners.com in 𝕏

Better Life Partners provides same-day medication-assisted treatment for opioid and alcohol addiction, combining counseling, community support, and medication for people in recovery.

Digital HealthHealthtechMental HealthHanover, US

Adam Groff(Executive Officer, Director)Juliana Ekong(Executive Officer, Director)Myechia Minter-Jordan(Director)Steven Kelly(Executive Officer)

BoardYair Schindel(Director)inJon Lim(Director)in

Co-investorsaMoon .406 Ventures Maverick Ventures

Bikam Pharmaceuticals

Bioconnect SystemsJan 2012

BiotechAmbler, US

Michael Dugery(Executive Officer, Director)Adam D. Dakin(Executive Officer, Director)

BoardRobert Weisskoff(Director)Charles G. Hadley(Director)

Biopalettebiopalette.co.jp

Co-investorsEight Roads Ventures

Bioregenbioregenmed.com

BioRegenMed is a high-tech company developing biomedical materials for trauma repair and tissue regeneration.

BiotechMedical DevicesNew MaterialsChangzhou, CN

Co-investorsEight Roads Ventures

Bison Trails

Black Ducksynopsys.com in 𝕏

Synopsys provides design automation tools and intellectual property for semiconductor and electronics companies to develop smart, connected devices.

Developer ToolsEnterprise SoftwareSemiconductorsBurlington, US

Doug Levin(Founder)Aart de Geus(Founder)inStephen N. Gregorio(Executive Officer)Philip B. Granof(Executive Officer)William NMN Ledingham(Executive Officer)Norman L. Shipley(Executive Officer, Director)

Co-investorsAsset Management Company Brightspark Ventures Crosslink Capital DataTribe Differential Ventures Francisco Partners +10 more

Blue Rabbitbluerabbit.vet in

Blue Rabbit is a veterinary online pharmacy platform that connects veterinary practices to Wedgewood's catalog of 46,000+ compounded medications along with pharmaceuticals, diets, and preventatives.

E-commerceHealthtechSaaS

Bluebird Kids Healthbluebirdkids.com in

Bluebird Kids Health provides pediatric care services with a family-centered approach.

Digital HealthHealthtech

Chris Johnson(Founder)in

Co-investors.406 Ventures AIF JUXTAPOSE VENTURES

Blueprint Medicinesblueprintmedicines.com in 𝕏

Blueprint Medicines is a biopharmaceutical company that discovers and develops targeted medicines for patients with diseases such as gastrointestinal stromal tumor and other conditions driven by genetic changes.

BiotechHealthtechCambridge, US

Nick Lydon(Director)Christoph S. Lengauer(Executive Officer)Christine Bellon(Executive Officer)Kyle Kuvalanka(Executive Officer)

BoardAlexis Borisy(Executive Officer, Director)Daniel Lynch(Director)

Co-investorsForesite Capital Nextech Invest RA Capital

Burroburro.ai in 𝕏Jan 2024 · $24M

Burro builds autonomous robots for agricultural and outdoor operations that mow, tow, carry, and spray to automate manual labor tasks.

AgTechAI & Machine LearningRobotics

Terry Scott(Founder)

Co-investorsAsimov Ventures Catalyst Investors Everywhere Ventures NextFab Ventures Radicle Growth S2G Investments +4 more

Cadence Neurosciencecadenceneuro.com inMay 2023 · $26M

Cadence develops a neuromodulation system intended to be a more effective, less invasive treatment for people living with drug-refractory epilepsy.

BiotechDigital HealthHealthtechMedical DevicesSammamish, US

Kent Leyde(Executive Officer, Director, Promoter)Warren Douglas Sheffield(Executive Officer, Director, Promoter)

Co-investorsJAZZ Venture Partners Lumira Ventures Angelini Ventures Iaso Ventures

Canary Technologiescanarytechnologies.com in 𝕏

Canary Technologies provides digital management software for hotels, replacing traditional paper-based administrative and operational workflows used across the hospitality industry.

Enterprise SoftwareSaaSNew York City, US

Harman Narula(Founder)inSJ Sawhney(Founder)in

Co-investors7BC Venture Capital Commerce Ventures DERIVE VENTURES Insight Partners Oyster Ventures Y Combinator +2 more

Candid

CandidProcandidco.com in

Candid develops clear aligner technology and offers remote monitoring services for dental professionals to deliver orthodontic treatment.

ConsumerDigital HealthHealthtechMedical Devices

Nick Greenfield(Co-founder & CEO)in

Co-investorsA-Rod Corp Averin Capital Bessemer Venture Partners Beyond Capital Kube VC Digitalis Ventures +2 more

Canoe Intelligencecanoeintelligence.com in

Canoe Intelligence provides AI-based software that collects alternative investment documents from GP portals and inboxes, then extracts and structures data such as capital calls, distribution notices, and partner capital account statements.

AI & Machine LearningFintechSaaS

PartnerDavid Jegen· led

Co-investorsInner Loop Capital Goldman Sachs

Capital Rx

Co-investorsAlumni Ventures B Capital Group Basecamp Fund Emerald Development Managers

Caplin Point Laboratoriescaplinpoint.net in

Caplin Point Laboratories is a publicly listed, vertically integrated pharmaceutical company that manufactures and markets finished drug products, including injectables and ophthalmics, across therapies on the WHO essential medicines list.

BiotechHealthtechChennai, IN

C.C. Paarthipan(Founder)

Cardiokline

Carestackcarestack.com in 𝕏

CareStack is a cloud-based, all-in-one dental practice management software covering scheduling, patient experience, clinical workflows, revenue cycle management, analytics, and compliance.

Digital HealthHealthtechSaaS

Co-investorsAccel Callapina Capital

Carrotcarrotfertility.com in 𝕏Jun 2023

Carrot is a global platform providing fertility care and family-building support to millions of people.

FemTechHealthtechHR TechRedwood City, US

Tammy Sun(Founder)inDavid Utley(Executive Officer, Director)

BoardSamir Kaul(Director)

Co-investorsBackstage Capital Drive Capital Maven Ventures Uncork Capital

Carrot Fertilityget-carrot.com in 𝕏Jun 2023

Carrot is a global fertility and family-building platform that provides access to fertility care, maternity support, and family-building guidance for individuals and families.

FemTechHealthtechSan Francisco, US

Asima Ahmad(Founder/CMO)inTammy Sun(Founder)in

Co-investorsAll Turtles Aurum Backstage Capital Core Venture Capital CRV (Charles River Ventures)Expansion Venture Capital +8 more

Cartesian Kineticscartesiankinetics.com in

Cartesian Kinetics builds warehouse automation that retrofits onto existing warehouse infrastructure to increase fulfillment throughput without facility redesigns.

HardwareLogistics & Supply ChainRobotics

Co-investorsCelesta Capital Celesta Capital Kae Capital

Casacasa.io in 𝕏

Casa provides self-custody solutions for bitcoin and stablecoins, offering multi-signature security infrastructure for both individual and institutional users.

Crypto & Web3Fintech

Co-investorsChampion Hill Ventures Fabric Ventures Fulgur Ventures STILLMARK Tioga Capital Partners Avon Ventures +1 more

Castlecastle.io in 𝕏

Castle builds trust infrastructure for the modern internet, helping organizations detect and prevent fraud and account takeover attacks.

CybersecurityDeveloper ToolsEnterprise SoftwareSaaSSan Francisco, US

Johan Brissmyr(Founder/CEO)inSebastian Wallin(Founder/CTO)in

BoardShardul Shah in

Co-investorsIndex Ventures Y Combinator First Round Capital Walking Ventures Boost VC SparkLabs Global Ventures +1 more

Castorcastoredc.com in

Castor provides an electronic data capture (EDC) platform for clinical trials and real-world evidence studies, combining eCOA/ePRO, eConsent, and clinical data management with AI-based extraction of source data into eCRFs.

AI & Machine LearningHealthtechSaaS

Co-investorsChartered Group Inkef Two Sigma Ventures

Centivo Health

Chaos Labschaoslabs.xyz in 𝕏

Chaos Labs builds AI-driven intelligence and risk-management infrastructure that converts fragmented data into institutional-grade insights, offering risk simulations, parameter tuning, and oracle technology for crypto protocols and financial institutions.

AI & Machine LearningCrypto & Web3Data & Infrastructure

Omer Goldberg(Founder & CEO)in

Co-investorsBalaji Srinivasan Coinbase Ventures Haun Ventures Lightspeed Venture Partners Samsung Next SCB 10X +6 more

Cipla Healthciplahealth.in in

Cipla Health is the consumer wellness arm of Cipla, offering a portfolio of over-the-counter healthcare and wellness brands including pain relief gels, antiseptics, cough and throat remedies, hygiene products, dietary supplements, and smoking-cessation aids.

ConsumerHealthtechWellness & Fitness

Citrine Medicine

Cloudantcloudant.com inAcquired

IBM Cloudant is a managed NoSQL database service based on Apache CouchDB, designed for building hyperscale, globally distributed applications with features including encryption, multi-region availability, full-text search, and geospatial indexing.

Cloud ComputingData & InfrastructureEnterprise SoftwareBoston, US

Michael Miller(Founder/Chief Scientist)inAlan Hoffman(Founder/Director of Product)inAdam Kocoloski(Founder/CTO)in

PartnerDavid Jegen· led

Co-investorsAvalon Ventures Management, Llc Carbide Ventures Toba Capital Y Combinator

Clstclst.com

CLST is a Zurich-based platform for institutional crypto and stablecoin lending with automated negotiation and risk assessment.

Michael Guzik(Founder)in

Co-investorsCoinbase Ventures Digital Currency Group SICTIC TX Ventures

Codeshipcodeship.com in 𝕏acquired by CloudBees

Cloud ComputingDeveloper ToolsEnterprise SoftwareSaaSBrookline Village, US

Moritz Plassnig(CEO)inSacha Labourey(Co-founder)François Déchery(Co-founder)Manuel Weiss(Executive Officer)Florian Motlik(Executive Officer)

BoardJohn SImon(Director)

Co-investorsAscent Venture Partners Camber Partners Golub Growth Matrix NewView Capital Rembrandt Venture Partners +4 more

Coin Metricscoinmetrics.io in 𝕏

Coin Metrics provides market and on-chain data, reference rates, and indexes for crypto and digital assets, delivered to institutional investment teams via APIs.

Crypto & Web3Data & InfrastructureFintechBoston, US

Timothy Rice(Executive Officer, Director)Tim Rice(Founder)in

BoardMathew S. McDermott(Director)Sean Judge(Director)inMatt Scott Walsh(Director)inNic Carter(Executive Officer, Director)in

Co-investorsAcrew Capital Coinbase Ventures Collab+Currency Communitas Capital Partners Digital Currency Group Dragonfly +2 more

Coincovercoincover.com in 𝕏

CoinCover provides crypto security and recovery infrastructure, including wallet disaster recovery, secure key management, and governance controls for digital assets.

Crypto & Web3CybersecurityFintech

David J.(Founder)in

Co-investorsInsurtech Gateway Fund 13books Capital Element Ventures Foundation Capital

ConnexPayconnexpay.com inOct 2022

ConnexPay provides a payment platform that lets businesses accept customer payments and fund immediate supplier payments via virtual cards from the same transaction, closing the cash flow gap.

FintechSaaSTravel & HospitalityBonita Springs, US

Robert Kaufman(Chief Executive Officer and member of the Board of Managers)inBob Kaufman(Founder)

BoardMark Buffington(Member of the Board of Managers)inJacob Eisen(Member of the Board of Managers)Pamela Joseph(Member of the Board of Managers)Barbara Polsky(Member of the Board of Managers)

Co-investorsBIP Ventures FTV Capital Tamiami Angel BIP Capital

Core Diagnosticscorediagnostics.in in 𝕏

Core Diagnostics offers diagnostic laboratory testing with sample collection services, including routine tests and diagnostic monitoring tests scheduled at defined intervals.

BiotechDigital HealthHealthtechMedical Devices

Co-investorsArtiman Ventures Eight Roads Ventures

Countablecountable.com

Actionable is a self-service advocacy platform that lets organizations launch, manage, and measure campaigns such as petitions, pledges, lawmaker messages, and supporter mobilization without developers or consultants.

GovTechImpact & Social GoodSaaSOakland, US

Bart Myers(Executive Officer, Director)

BoardJoydeep Bhattacharyya(Director)in

Co-investorsCanaan Partners Fernbrook Capital Management Silicon Valley

Countable Labscountablelabs.com in 𝕏

Countable Labs (formerly Enumerix) develops Countable PCR, a DNA quantification technology that provides absolute target counts at single-molecule resolution as an alternative to qPCR, digital PCR, and NGS.

BiotechDeep TechHealthtechMedical Devices

Stephen Fodor(Co-Founder & Board Director)Ari Chaney(Co-Founder & Board Director)inGiovanna Prout(CEO & Board Director)in

Co-investorsARCH Venture Partners Primer Ventures

Curegenix Corporation

Curie Biocurie.bio in

Curie.Bio is a biotech venture firm pairing seed capital with in-house drug discovery support for therapeutics founders.

Zach Weinberg(Founder)in

Co-investorsAlleyCorp ARCH Venture Partners DNA Capital GV (Google Ventures)Shine Capital Alley Robotics Ventures +1 more

Curvancecurvance.com 𝕏

Curvance is a decentralized finance protocol that combines depositing, borrowing, leveraging, swapping, and yield earning into a single dashboard.

Crypto & Web3Fintech

Co-investorsV3V Ventures Yunt Capital Curve Flowdesk FRAX Finance GSR +2 more

Cyclopscyclops.io in 𝕏

Cyclops is a unified crypto and stablecoin platform built specifically for payments companies, combining licensing, custody, compliance, and 24/7 settlement into a single integration.

Crypto & Web3FintechSaaS

Alex Wilson(Founder)in

Co-investorsNava Ventures

Dataplordataplor.com in 𝕏

dataplor provides a global location intelligence platform offering data on over 200 million points of interest and privacy-compliant foot traffic signals.

AI & Machine LearningData & InfrastructureEnterprise Software

Co-investorsAPA Venture Partners Blue Ivy Ventures Circadian Ventures Magma Partners Navigate Ventures Quest Venture Partners +3 more

Deal Enginedealengine.tech in

Deal Engine builds white-labelled dealmaking platforms for investment banks and private equity firms, unifying internal, external, and public data into a single intelligence layer connected to LLMs.

AI & Machine LearningFintechSaaSLondon, GB

Phil Westcott(CEO)

Co-investorsFINTOP Capital Thayer Ventures

Deal Enginedeal-engine.com

Deal Engine is a travel software company that uses proprietary AI and APIs to automate manual processes for airlines and travel agencies.

AI & Machine LearningSaaSTravel & HospitalityMiami, US

Co-investorsDorm Room Thayer Ventures

Devoted Healthdevoted.comOct 2017

Devoted Health offers Medicare Advantage plans and integrated healthcare services for older Americans, including virtual and in-home care, member support guides, and coordination with local providers across 29 states.

HealthtechInsurTechUnited States, US

Todd Park(Co-founder)inEdward Park(Executive Officer, Director)Ed Park(Co-founder)in

BoardBryan Roberts(Director)inRobert Kocher(Director)inWilliam Frist(Director)

Co-investorsAndreessen Horowitz Bronze Investments Capital Factory Dns Capital Dreamers VC FPV +18 more

Digital Assets Data

Dimension TherapeuticsApr 2015

Cambridge, US

Annalisa Jenkins(Executive Officer, Director)

BoardBenjamin Auspitz(Director)Donald J. Hayden(Director)Allan Fox(Director)

Co-investorsNew Leaf Venture Partners OrbiMed

Dinaridinari.com in 𝕏

Dinari provides tokenized stocks and ETFs (dShares) that combine traditional equity securities with blockchain-based digital assets, serving financial institutions like neobanks, fintechs, brokerages, and institutional traders across 85+ jurisdictions.

Crypto & Web3FintechPalo Alto, US

Gabriel Otte(Executive Officer, Director)inAltay MalazgirtJake Timothy

Co-investors500 Global Alliance DAO (ex DeFi Alliance)Hack VC Sancus Ventures Silvermine Capital

Dispatch

Dispatch iodispatch.io in

Dispatch is a data orchestration platform that connects wealth technology software by automating client data collection and synchronization across advisory firm tech stacks.

Data & InfrastructureEnterprise SoftwareFintechSaaS

Rob Nance(Co-founder, CEO)inMadalyn Armijo(Co-founder, COO)inRafi Lurie(Co-founder, CPO)in

Co-investorsBrewer Lane Ventures Fika Flyover Capital MassMutual Ventures New York Life Ventures Perceptive Ventures Management Company, Llc +3 more

Docereedoceree.com in 𝕏Sep 2023 · $35M

Doceree offers a software platform for pharmaceutical brand teams, positioned as a single "system of work" that unifies market research, HCP targeting, media planning, measurement, CRM, and MLR workflows in place of fragmented tools.

AdTechDigital HealthMarketing TechSaaSShort Hills, US

Harshit Jain(Founder & Global CEO)inKamya Elawadhi(Co-Founder & President)inPulkit Jain(VP - Finance & Investments)Vijay Adapala(Chief Business Development Officer)inThomas Shea(Chief Revenue Officer, AI and Patient Affordability Solutions)inYesh Srinivasan(Chief AI Officer)

Co-investorsAlkemi Growth Capital Eight Roads Ventures

Dust Identitydustidentity.com in

Dust Identity uses engineered diamond-dust to create discreet, clone-proof object markers, each tied to a digital record that tracks the object over its lifespan.

Deep TechHardwareNew MaterialsNeedham, US

Ophir Gaathon(Executive Officer, Director)Dirk Englund(Executive Officer, Director)

BoardIlya Fushman(Director)

Co-investorsAngular Ventures Grit Ventures New Science Ventures Kleiner Perkins Lockheed Martin Ventures

Eaglebrook Advisorseaglebrook.com

Eaglebrook is a crypto investment platform for wealth managers, offering tax-optimized Bitcoin, Ethereum, and multi-asset separately managed accounts (SMAs) held in segregated accounts at qualified custodians.

Crypto & Web3FintechSaaS

Christopher King(Founder)in

Co-investorsBrewer Lane Ventures Avon Ventures Castle Island Ventures Franklin Templeton Gemini Frontier Fund Jump Capital

Eigeneigen.io inAug 2026 · $20M

Eigen Innovations applies AI-powered thermal vision to manufacturing, using thermal imaging and machine learning to detect product defects (such as voids, adhesion issues, and material inconsistencies) and continuously monitor equipment and process temperatures.

Advanced ManufacturingAI & Machine LearningHardware

Co-investorsCeltic House Asia Partners East Valley Ventures Momenta Ventures AGI HOUSE VENTURES Aramco Ventures Benchmark +7 more

Elementuselementus.io in

New York, US

Max Galka(Executive Officer, Director)Nuria Gutiérrez Prunera(Founder)Chris LipowiczinNuria Gutierrez Prunera(Executive Officer, Director)Vladimir Jelisavcic(Director)

BoardAnthony Pompliano(Director)

Co-investorsMoonshots Capital ParaFi Capital Velvet Sea Ventures Morgan Creek Capital

Eleos Healtheleos.health inNov 2023 · $40M

Eleos develops AI-powered software that helps behavioral health clinicians deliver more effective care through data measurement and personalization.

AI & Machine LearningDigital HealthHealthtechMental HealthCambridge, US

Alon Joffe(Chief Executive Officer)inDror Zaide(Chief Revenue Officer)inAlon Rabinovich(Chief Technology Officer)inDenny Morrison(Chief Clinical Officer)inRaz Karmi(Chief Information Security Officer)inNoam Cohen(VP of R&D)in

Co-investorsaMoon Arkin Capital Greenfield Partners Lool Ventures Maccabee Ventures Menlo Ventures +2 more

Elucidataelucidata.io in 𝕏

Elucidata is a company oriented around supporting scientific research, emphasizing making users' research more efficient and respecting the scientific method.

AI & Machine LearningBiotechData & InfrastructureCambridge, US

Abhishek Jha(Co-founder & CEO)Swetabh Pathak(Director)

Co-investorsHyperplane Venture Capital Eight Roads Ventures IvyCap Ventures

Embarkembarkvet.com in 𝕏

Embark Veterinary develops dog DNA tests and science-backed supplements for dog health and genetics.

BiotechConsumerHealthtech

Amish Desai(Chief Executive Officer)Tali Ronen(SVP, People)Grace Carter(VP, Finance)

Co-investorsDCVC (Data Collective)FundersClub Peak Partners Slow Ventures SoftBank Vision Fund Sequoia Capital

Engrail Therapeuticsengrail.com in

Engrail Therapeutics is a clinical-stage pharmaceutical company developing precision-targeted therapeutics for neupropsychiatric and neurodevelopmental disorders.

BiotechDigital HealthMedical DevicesSan Diego, US

Stephen(Co-founder, EVP Research & Development and Chief Development Officer)Paul Cayer(Chief Financial Officer)Vikram(President and Chief Executive Officer)Kimberly(Chief Scientific Officer)Quentin(Chief Technical Officer)

Co-investorsForesite Capital Longwood Fund Norwest Venture Partners RiverVest Venture Partners Ysios Capital abrdn plc +4 more

Enzene Biosciences Ltdenzene.com in 𝕏

Enzene Biosciences is a biologics company focused on the development and manufacturing of biopharmaceuticals.

Advanced ManufacturingBiotechHealthtechMedical Devices

Co-investorsEight Roads Ventures

Equipequip.health in 𝕏

Equip provides virtual care and treatment services for eating disorders through a digital platform.

Digital HealthHealthtechMental Health

Kristina Saffran(CEO & Co-Founder)inErin Parks(Chief Clinical Officer & Co-Founder)

Co-investors.406 Ventures Coalition Operators Optum Ventures PLUS Capital The Chernin Group (TCG Crypto)

Eris Innovationserisfutures.com

Eris Innovations is an intellectual property licensing company that developed and patented the Eris Methodology, a way to list exchange-traded futures replicating interest rate swaps, which it licensed to CME Group for Eris SOFR Swap futures and Eris Options.

Fintech

Michael Riddle(Chief Executive Officer)in

Ethena

Ethena Labsethena.fi 𝕏

Ethena operates a crypto protocol offering USDe, a digital dollar, and sUSDe, a reward-accruing asset backed by collateralized assets with third-party attestations.

Crypto & Web3Fintech

Guy Young(Founder & CEO)in

Co-investorsAlphaLab Capital BitDAO Breed Caladan CVP NoLimit Faction +17 more

EurekaBioeurekabio.com in

EurekaBio develops technologies and solutions for the cell and gene therapy (CGT) industry, focused on treatments for diseases such as cancer, rare diseases, genetic disorders, and auto-immune conditions.

BiotechDeep TechHardwareHealthtechMedical DevicesShenzhen, CN

Co-investorsMing capital

Eurkeabio

Even Financialevenfinancial.com inAcquired

Even Financial, operating as Engine, runs a financial services marketplace and matching network that connects consumers with financial products through APIs and white-labeled experiences.

AI & Machine LearningFintechMarketplacesBrooklyn, US

Phill Rosen(Founder & CEO)Ian Rosen(Executive Officer, Director)Jarid Maged(Executive Officer, Director)

BoardBrendan Dickinson(Director)in

PartnerDavid Jegen· led

Co-investorsAAF Management Ltd.Conversion Capital GreatPoint Ventures MassMutual Ventures Valuestream Ventures Canaan Partners +4 more

Expressableexpressable.io

Austin, US

Nicholas Barbara(Executive Officer, Director)inLeanne Sherred(Executive Officer, Director)Benjamin Pincus(Executive Officer)Spencer Magloff(Executive Officer)Ryan Hinojosa(Executive Officer)

Co-investorsNextView Ventures HarbourVest Partners (Canada)

Eyebright Medical

Eywaeywa.bio in

Eywa produces clinical-grade psychedelic compounds — including psilocybin, DMT, 5-MeO-DMT, and bufotenine — as APIs and finished drug products made through biosynthesis for use in scientific research, clinical trials, and commercial mental health applications.

BiotechDigital HealthMental Health

Co-investorsDraper Associates Ganesha Lab GRIDX ah! Ventures

FalconXfalconx.io in 𝕏

FalconX is a digital assets prime brokerage providing institutional clients with 24/7 access to liquidity and capital solutions through proprietary technology designed for risk management in volatile markets.

Crypto & Web3FintechSan Mateo, US

Raghu Yarlagadda(Founder)inAustin Reid inSuzy Walther inBrian Crist inVanessa Zhang in

BoardShekhar Kirani(Executive Officer, Director)in

Co-investorsAccel Accomplice B Capital Group B4 Capital Cleo Capital Coinbase Ventures +11 more

Farapulse

Fazeshift

Fcb Health

Figmentfigment.io in 𝕏

Figment is an independent provider of staking infrastructure, offering non-custodial staking, reward tracking, API integrations, and slashing protection to institutional clients such as asset managers, exchanges, wallets, foundations, and custodians.

Crypto & Web3Data & InfrastructureEnterprise SoftwareFintech

Lorien Gabel(Founder & CEO)in

Co-investors10SQ Capital (TenSquared)3cubed Ventures AppWorks Ventures Archetype B Capital Group B4 Capital +10 more

Firefly Healthfirefly.health in

Firefly Health operates an advanced virtual care platform designed to deliver primary care services with a focus on equity, affordability, and personalized patient outcomes.

Digital HealthHealthtechInsurTech

Andy Ellner(Chief Clinical Advisor)Jeff Greenberg(Founder)inFay Rotenbergin

Co-investorsAndreessen Horowitz MaC Venture Capital Oak HC/FT Premji Invest Jam Fund

Flipside Cryptoflipsidecrypto.com

Edisyl builds a semantic layer that encodes organizational understanding of data meaning, metrics definitions, and institutional knowledge to enable enterprise AI tools to answer questions aligned with business logic.

AI & Machine LearningData & InfrastructureEnterprise Software

Jim Myers(Founder)in

Co-investorsBoston Seed Capital Coinbase Ventures Converge The Chernin Group (TCG Crypto)Collaborative Fund Flucas Ventures +2 more

Flourish Health

Flywireflywire.com in 𝕏

Flywire is a global payments platform and software company that enables complex international payments across education, healthcare, travel, and B2B sectors.

Enterprise SoftwareFintechSaaSBoston, US

Iker MarcaideMike Massaro(CEO)in

PartnerDavid Jegen· led

Co-investors500 Global Accel Bain Capital Ventures Balderton Capital Boston Seed Capital Kibo Ventures +5 more

Foldrx

Funnelfunnel.io in 𝕏

Funnel is a marketing data platform that connects to 600+ advertising, analytics, and sales sources to centralize, clean, and govern marketing data for delivery to warehouses, BI tools, and AI/agentic workflows.

Data & InfrastructureMarketing TechSaaS

Co-investorsBalderton Capital Industrifonden NavisionGroup Oxx Trinity Ventures Camber Creek +1 more

FutureAdvisorfutureadvisor.comacquired by BlackRock

FutureAdvisor provides digital wealth management services to middle- and upper-middle-income households, offering automated portfolio management and financial advice at lower costs than traditional advisory firms.

FintechSan Francisco, US

Bo Lu(Founder/CEO)in

PartnerDavid Jegen· led

Co-investorsCanvas Ventures Kapor Capital Y Combinator Sequoia Capital

Galatea Biogalatea.bioAug 2024

Genomics company building a multi-ancestry biobank and AI-driven analytics for clinical genetic testing and drug discovery.

HealthtechMiami Lakes, US

Carlos D. Bustamante(Executive Officer, Director)Arthur Polk(Executive Officer)Alexander Ioannidis(Director)

BoardWale Ayeni(Director)inMohit Kaushal(Director)Nicholas Katsanis(Director)

Co-investorsCEI Ventures Citta Capital Founder Collective Function Ventures Helios Digital Ventures LifeX Ventures +2 more

Geneceptionskytx.com in

Skyline Therapeutics develops gene therapies using an adeno-associated virus (AAV) platform that combines capsid discovery, vector engineering, process development, and GMP manufacturing.

BiotechHealthtech

Co-investorsLAV Lilly Asia Ventures

Genomics Plcgenomics.com in 𝕏

Genomics builds a genotype-phenotype database and genetic risk-prediction tools used to support pharmaceutical drug discovery and clinical trials, as well as population health management and clinical decision support for healthcare providers.

AI & Machine LearningBiotechDigital HealthHealthtechOxford, GB

Peter Donnelly

Co-investorsForesite Capital

Geotel

Grovegrove.city

Grove, originally founded as Pocket Network Inc., built decentralized infrastructure including the Pocket Network protocol and the Grove Portal gateway serving blockchain data access.

Creator EconomyCrypto & Web3Data & Infrastructure

Michael O'RourkePabel NunezinLuis de Leonin

Co-investorsBorderless Venture Outliers VC

Gst Clinicsgstzy.cn

Gushengtang operates a chain of traditional Chinese medicine (TCM) clinics, running 101 offline TCM facilities across 21 Chinese cities and Singapore with an online-plus-offline (OMO) service model supported by internet and AI technology.

AI & Machine LearningDigital HealthHealthtechWellness & FitnessGuangzhou, CN

Co-investorsNew Enterprise Associates (NEA)AGP

Gurosguros.com

Guros is an online platform for comparing and buying car insurance in Mexico, letting consumers compare prices, coverage, and benefits from up to 8 insurers at once.

FintechInsurTechMarketplaces

Co-investorsCapria Ventures Clocktower Ventures LEAP Global Partners Magma Partners

Gyennogyenno.com

Co-investorsQiming Venture Partners

Health Technologyhaici.com

Co-investorsVertex Ventures China

Healthcare North America Growth Stageartbio.com in 𝕏Dec 2023

ARTBIO develops alpha radioligand therapies (ARTs) for cancer treatment, designing target-and-molecule combinations intended to kill tumors while sparing healthy tissue.

BiotechHealthtechMedical DevicesOslo, NO

Roy Larsen(Scientific Founder)Øyvind Bruland(Scientific Founder)Jonathan Freeman(Interim CEO)Margaret Yu(Chief Medical Officer)Philippe Dasse(Chief Technical Officer)Amra Demirovic(Chief Human Resources Officer)

Co-investorsB Capital Group B4 Capital Alexandria B Capital Qatar Investment Authority Sofinnova Ventures+1 more

Healthcare North America Growth Stagecentivo.com in

Centivo is a primary-care-centered health plan administrator for self-funded employers, sold through benefits brokers and consultants.

Digital HealthHealthtechInsurTech

Alan Cohen(Founder)inAshok Subramanian(Founder & CEO)Stuart Roth(Founder)in

Co-investorsAlumni Ventures B Capital Group B4 Capital Basecamp Fund GPO Fund Maverick Ventures+5 more

Browse all 439 investments with full details →

▶239 more tracked companies

Healthtech + ServicesHercle HilabsHile BiopharmaHone HosekiHq Medical TechnologyHua Medicine iCertis, Inc.IgluIkano TherapeuticsImmuneelImmutrinIndalo TherapeuticsInnoventInnovent BiologicsInsilico Medicine Intuition Invetx Iora Health Iriva Medical Ironwood Pharmaceuticals IvenixJ PharmaJumpK36 TherapeuticsK36 TxKanastra KenshoKilnKintsuKnowyourselfKryuus IncLakeShore Biopharma Latchel Laurus Bio Laurus LabsLeadiqLemonLenomedLiazonLighthouseLigocyteLimitless ExchangeLogixboard MadaketMarit HealthMddfMedbanksMediTrust HealthMedwellMeldMersana Metcela MetseraMindshiftMineralTreeModis TherapeuticsMoEngageMonark MarketsMyolabMythical Games Nanos MedicalNapsterNava Therapeutics nChroma BioNebulaNebula Genomics Neo4jNeurosmartNextwave PharmaceuticalsNextwavepharmaNflection Therapeutics nocd Nocion Therapeutics NodtheraNotableNovamed PharmaceuticalsNuance CommunicationsNvelop TherapeuticsNYDIGOakley NetworksOdaseva OncoveryCare Oncusp TherapeuticsOnCusp TxOpennode Optimus Ride Orchard TherapeuticsOrient Speech Therapy OstOrigynmedOvivaOviva PRIVATE DEBTOwkinOwncloud IncOxioOzivaPapaya PaymentsParadigmParrotPathPatientPingPediatrixPediatrix TherapeuticsPeptonePercyPharmEasyPiePing Identity Plasmagen Biosciences Plume NetworkPortfolio Category AiPortfolio Category CryptoPortfolio Category EnterprisePortfolio Category FintechPortfolio Category FrontierPortfolio Category MedtechPortfolio Category TherapeuticsPortfolio Region AsiaPortfolio Region EuropePortfolio Region NaPortfolio Region South AmericaPortfolio Status AcquiredPortfolio Status PrivatePortfolio Status PublicProcured HealthPromentis Pharmaceuticals Prosper ProtenusProteostasis TherapeuticsProximiePuffer FinancePulmocide Quantum Circuits Quarry Thera Quartet Health QuovoR1 TherapeuticsRareStone GroupReadmeReceipts Depositary CorporationRecurlyRedpine Regenx BiosciencesRemunixRespivertRhyGazeRhyGaze AG Rialtic RightHand RigimmuneRipplRisklensRiskreconRoarkRugen TherapeuticsSana Biotechnology Securonix Semma TherapeuticsSemma TxSeyond Shift Bioscience Shinobi Therapeutics Inc.Shinobi TxSilexonSilicon DataSilqSimonSingular GenomicsSingular Genomics Systems SironaxSkyline TxSnapsheet Solidus LabsSolv ProtocolSonderMind Space and Time Spectrumai Spinwheel SpryStride HealthStructure TherapeuticsSts DigitalSurface OncologySymbiomixT Therapeutics TandemaiTct Medical IncTeam Sector CryptoTeam Sector Life SciencesTeam Sector TechnologyTeleoTenpoint Therapeutics TenvieTetraphase PharmaceuticalsThe Giving BlockTokensoftToku TokuTokuTopaz PharmaceuticalsTraceLinkTradeblockTransaveTreeentTrivitron HealthcareTruth SystemsTurnstone BiologicsTwin1 AiU S HealthVest Ultragenyx Unbox RoboticsUnbxdUnlocking mRNA deliveryUnlocking private, uncensored AIValor HealthValrVendrVeridVerve Therapeutics VestwellVicept TherapeuticsVitalwareVyne TherapeuticsWanhu HealthcareWarmlyWarmly,Welbe Healthwell beam Wellframe WhatfixWintermuteWww Akrevia ComXaira TherapeuticsXoomYishengbioZeen HealthZusジェイファーマ株式会社

Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.

Exits · 24

IPOs and acquisitions across the tracked portfolio

Caribou BiosciencesNASDAQ: CRBUNeumora TherapeuticsNASDAQ: NMRApeerTransferNASDAQ: FLYWShouTi Inc.NASDAQ: GPCRXilio TherapeuticsNASDAQ: XLOAclaris TherapeuticsNASDAQ: ACRSAdageneNASDAQ: ADAGAvalyn Pharma IncNASDAQ: AVLNBeam TherapeuticsNASDAQ: BEAMBicara TherapeuticsNASDAQ: BCAXCoherus BiosciencesNASDAQ: CHRSCoinbaseNasdaq: COINCompass TherapeuticsNASDAQ: CMPXCytek BiosciencesNASDAQ: CTKBDenali TherapeuticsNASDAQ: DNLIInsmedNASDAQ: INSMPony AiNASDAQ: PONYPrecision BioSciencesNASDAQ: DTILPrime MedicineNASDAQ: PRMERallybio, LLCNASDAQ: RLYBToastNYSE: TOSTUnum TherapeuticsNASDAQ: COGTCodeshipacq. by CloudBeesFutureAdvisoracq. by BlackRock

Portfolio news

latest coverage across their companies

AI-powered digital ‘double’ platform start-up Twin1 raises $20m in seed funding round - The Global Legal Post

Eigen · globallegalpost.com · Aug 21, 2026

Devoted Health is raising a new round of funding at a $25 billion valuation

Devoted Health · businessinsider.com · Aug 21, 2026

Ethena’s ENA Rockets 50% on Arthur Hayes Endorsement and $1B FalconX Partnership

Ethena Labs · interactivecrypto.com · Aug 21, 2026

State funding will help Garden Grove recoup chemical incident costs. Nearby cities were denied – Orange County Register

Grove · ocregister.com · Aug 20, 2026

Canaccord raises Ultragenyx stock price target on FDA approval By Investing.com

Ultragenyx · investing.com · Aug 20, 2026

Bombshell: El-Sayed's Birth Mother Helped Funnel Money to Taliban and Bin Laden? UPDATE – HotAir

Funnel · hotair.com · Aug 19, 2026

FOA raises more than $400,000 to help restore the historic Baker Island Lighthouse | News | ellsworthamerican.com

Lighthouse · ellsworthamerican.com · Aug 19, 2026

Iglu Ski team raise £700 for charity in 'superhero triathlon' | TTG

Iglu · ttgmedia.com · Aug 19, 2026

Frequently asked questions

How many investments has F-Prime Capital made?: F-Prime Capital has 434 tracked investments, 18 of which have exited via acquisition or IPO, including 6 dated in the last 24 months.
What stage does F-Prime Capital invest at?: F-Prime Capital invests at the Pre-Seed, Seed, Series A, Series B, Series C, Growth, Late Stage stages.
What is F-Prime Capital's typical check size?: F-Prime Capital typically writes checks of $3M – $10M.
What sectors does F-Prime Capital focus on?: F-Prime Capital focuses on Biotech, Crypto & Web3, Deep Tech, Digital Health, Enterprise Software, Fintech, Healthtech, Medical Devices, SaaS, Sector Agnostic.
Where is F-Prime Capital located?: F-Prime Capital is headquartered in Cambridge, US.
Does F-Prime Capital lead rounds?: Yes, F-Prime Capital leads investment rounds.
Who does F-Prime Capital co-invest with?: F-Prime Capital most often shares deals with ARCH Venture Partners, Eight Roads Ventures, GV (Google Ventures), among 651 tracked co-investors.

Images

Co-investors · 167

Eight Roads Ventures

Eight Roads Ventures is a venture capital firm that backs and partners with technology and healthcare companies.

Both backed · 32

Adagene Beam TherapeuticsBicara TherapeuticsAbk Biomedical Inc Adaptimmune Adcentrx Therapeutics Affinia Therapeutics AppsFlyer Arnatar Therapeutics AvenCell Beads Bioregen Core Diagnostics Doceree Eleos Health Elucidata Engrail Therapeutics Enzene Biosciences Ltd Hua Medicine K36 Therapeutics Laurus Bio Laurus Labs MineralTree Odaseva Oziva Spry Threat Stack WhatfixAlphagen TherapeuticsB One OrthoBetter Life MedicalBiopalette

$5M – $30M

GV (Google Ventures)

GV (Google Ventures) is a venture capital firm that has invested in artificial intelligence and machine learning since its early days, building a global portfolio of more than 100 AI companies across infrastructure, life sciences, and applications.

Both backed · 18

Beam Therapeutics Denali Therapeutics Prime Medicine Aera Therapeutics Affinia Therapeutics AI biotech Comanche Biopharma Curie Bio Devoted Health Invetx Iora Health Leyden Labs Metsera Neo4j PatientPing Quartet Health RhyGaze AG Verve Therapeutics

$250K – $50M

ARCH Venture Partners

ARCH Venture Partners is a venture capital firm that invests in and helps build transformational companies, with a strong focus on the life sciences and biotechnology sector.

Both backed · 18

Beam Therapeutics Denali Therapeutics Neumora Therapeutics Prime Medicine Aera Therapeutics Countable Labs Curie Bio Hua Medicine Metsera nChroma Bio Quantum Circuits RhyGaze AG Sana Biotechnology Singular Genomics Systems Sironax Tenvie Verve Therapeutics Xaira Therapeutics

$50K – $250M

Foresite Capital

Foresite Capital is a healthcare-focused investment firm backing companies at the intersection of technology and biotechnology to personalize healthcare and accelerate medical innovation.

Both backed · 14

Aclaris Therapeutics Beam Therapeutics Compass Therapeutics Denali Therapeutics InsmedBicara TherapeuticsBlueprint Medicines Engrail Therapeutics Generation Bio Genomics Plc Orchard Therapeutics Verve Therapeutics Xaira TherapeuticsStructure Therapeutics

New Enterprise Associates (NEA)

New Enterprise Associates (NEA) is a venture capital firm that invests in and provides long-term support to founders building new companies.

Both backed · 13

Adaptimmune Affinia Therapeutics Amber Therapeutics AviadoBio Website Black Duck CHARM Therapeutics Comanche Biopharma Gst Clinics Mersana Tempest Therapeutics Xaira TherapeuticsProteostasis TherapeuticsSurface Oncology

$200K – $40M

OrbiMed

OrbiMed is a global healthcare-focused investment firm providing financing and operational support to companies across biopharmaceuticals, medical devices, digital health, diagnostics, and healthcare services.

Both backed · 12

Compass Therapeutics Insmed Adelabio Carrot Fertility CHARM Therapeutics Dimension Therapeutics Insilico Medicine Oncusp Therapeutics Promentis Pharmaceuticals Tandemai Turnstone Biologics Viewray

$1M – $75M

Andreessen Horowitz

Andreessen Horowitz (a16z) is a venture capital firm founded in 2009 by Marc Andreessen and Ben Horowitz, known for pioneering the platform model with a large team of operators supporting founders across stages.

Both backed · 10

Coinbase Benchling Devoted Health Dispatch io Firefly Health Mythical Games Nava Therapeutics PatientPing Prosper Zus Health

$500K – $50M

Bessemer Venture Partners

Bessemer Venture Partners is a global venture capital firm that partners with entrepreneurs across enterprise, consumer, and healthcare sectors from early stages through growth.

Both backed · 9

Insmed Toast Artemis Health CandidPro Eigen NYDIG Peptone PharmEasyLiazon

$5M – $100M

B Capital Group

B Capital is a global investment firm backing early to late-stage technology innovators across technology, healthcare, and energy & resilience sectors.

Both backed · 9

FalconX Figment iCertis, Inc.Insilico Medicine MoEngageARTBIOCapital RxHealthcare North America Growth StageMediTrust Health

$10M – $50M

SoftBank Vision Fund

SoftBank Vision Fund invests globally in AI-focused companies working to transform and create industries.

Both backed · 9

Neumora Therapeutics Devoted Health Embark iCertis, Inc.Metsera Proximie RightHand Vendr Whatfix

Sofinnova Ventures

Sofinnova is an investment firm focused on the life sciences and biotechnology sector, partnering with companies from inception through drug development, regulatory approval, company building, and IPO.

Both backed · 9

Aclaris Therapeutics Coherus Biosciences Checkmate Pharmaceuticals Oncusp Therapeutics RarecyteApellisHealthcare North America Growth StageNextwavepharmaProteostasis Therapeutics

$100K – $15M

Atlas Venture

Atlas Venture is a life sciences venture capital firm with three decades of experience investing in and building biotech and medical innovation companies, including startups launched from its own incubator.

Both backed · 7

Unum Therapeutics Xilio Therapeutics Affinia Therapeutics Comanche Biopharma Generation Bio K36 Therapeutics nChroma Bio

$500K – $1M

▶155 more co-investors

RA Capital .406 Ventures Canaan Partners Venrock Digital Currency Group Menlo Ventures Oak HC/FT 5AM Ventures Vivo Capital Volition Capital General Catalyst Accel Spark Capital QED Investors Sanofi Ventures Lightstone Ventures RiverVest Venture Partners Sequoia Capital Khosla Ventures Alumni Ventures Insight Partners Bain Capital Ventures Tiger Global Management NextView Ventures Polaris Partners Social Leverage MassMutual Ventures JAZZ Venture Partners Sofinnova Partners Maven Ventures Digitalis Ventures Brewer Lane Ventures Nextech Invest Advent Life Sciences Greylock Partners Index Ventures Founder Collective Plug and Play Ventures Gradient Ventures Lux Capital Forerunner Ventures Inovia Capital Winklevoss Capital Fika 9Yards Capital Jump Capital Pivotal Life Sciences Arboretum Ventures Optum Ventures aMoon Anterra Capital AIF Red Tree Venture Founders Fund Craft Ventures Redpoint Ventures Benchmark First Round Capital Kleiner Perkins Foundation Capital CRV (Charles River Ventures)Eniac Ventures FundersClub Freestyle Capital SignalFire Scale Venture Partners Canvas Ventures Maveron Lerer Hippeau US Venture Partners Creandum Two Sigma Ventures Threshold Ventures Citi Ventures Founders' Co-op Accelerator Ventures Jackson Square Ventures Dawn Capital Golden Ventures Kickstart Pitango Xfund EQT Life Sciences Versant Ventures Forbion Cambridge Innovation Capital SparkLabs Global Ventures Third Rock Ventures Flagship Pioneering 7wire Ventures GPO Fund Baird Capital Inkef Omega Funds Illuminate Financial Questa Capital Brighton Park Capital CVS Health Ventures DFJ Flyover Capital Casdin Capital Bluebird Ventures Helios Digital Ventures Alkemi Growth Capital Great Oaks Venture Capital Streamlined Ventures RRE Ventures UpHonest Capital Headline IA Ventures Pear VC Upfront Ventures Wing General Partnership Dell Technologies Capital Better Tomorrow Ventures Saga Ventures Brainchild Holdings TCV Company Capital Heartcore Capital Flourish Ventures Work-Bench American Express Ventures (Amex)Mucker Capital Nyca Partners Ff Venture Capital BDC Venture Capital Highbury Holdings Rubicon Venture Capital IrishAngels Forum Ventures Stripe Arrive Bread And Butter Ventures, Llc Page One Ventures Abingworth Venture Guides Management, L.P.Firefly Health Picture Capital Zelkova Ventures Arthur Ventures In-Q-Tel Town Hall Ventures Surface Ventures HealthQuest Capital Fireblocks 4BIO Capital Vendep Capital JMI Equity De Novo Ventures Neon Adventures Nina Capital International Finance Corporation WillowWorks

Firms observed investing alongside F-Prime Capital, from public investor directories. Shared companies are the overlap with F-Prime Capital's recorded portfolio.

Similar investors

B Capital Group

B Capital is a global investment firm backing early to late-stage technology innovators across technology, healthcare, and energy & resilience sectors.

$10M – $50M

Khosla Ventures

Khosla Ventures is a venture capital firm that invests in early-stage companies focused on technology, mobile, and clean energy sectors, including biotechnology applications. The firm provides capital and strategic support to entrepreneurs developing breakthrough technologies across multiple markets.

$5K – $50M

DCVC (Data Collective)

DCVC (Data Collective) is a deep tech venture capital firm that backs entrepreneurs using computational approaches to solve large-scale real-world problems across many industries.

$5M – $25M

Kleiner Perkins

Kleiner Perkins is a venture capital firm that backs founders across technology and life sciences, from early stage through growth.

$500K – $15M

Basecamp Fund

A globally recognized venture capital firm designed to provide access to highly competitive venture deals to individual investors, consistently recognized for top-decile DPI performance and as one of the most active US venture firms.

$100K – $10M

Featured in lists

Investors & VC Firms in North America Investors & VC Firms in United States Seed Investors & VC Firms Series A Investors & VC Firms Pre-Seed Investors & VC Firms Seed Investors & VC Firms in North America Investors & VC Firms in Europe Seed Investors & VC Firms in United States Growth Investors & VC Firms Crypto & Web3 Investors & VC Firms Series A Investors & VC Firms in North America Series B Investors & VC Firms

Website & socialfprimecapital.com

/f-prime-capital-partners @fprimecapital watch video

signal ↗crunchbase ↗Blog ↗

As published on the firm's website.

Contact

Cambridge1 Main St.
13th Floor
Cambridge, MA 02142
United States

London33 Foley Street
London W1W 7TL
United Kingdom

San Francisco140 New Montgomery Street
2nd Floor, Suite A
San Francisco, CA 94105
United States

Emailinfo@fprimecapital.com

Phone617-231-2400

Fax617-231-2425

FoxScore

Combines investment activity, responsiveness, founder feedback, closing rate and follow-through reported by founders on Fox. Sign up to see it.

Your history

F-Prime Capital isn't in your CRM yet.

+ Add to CRM

Track outreach, deck opens, and next steps across your whole raise.

✨ Smart outreach

✨ Best warm path

Funds

IMPRESA FUND IV LLCJun 2026 · 301 LPs$3.5BAUM

FMR CAPITAL HOLDINGS LLCJun 2026 · 298 LPs$3.1BAUM

IMPRESA FUND III LPJun 2026 · 138 LPs$2.7BAUM

42 NORTH RESOURCE PARTNERS II LPJun 2026 · 2 LPs$609.3MAUM

F-PRIME CAPITAL PARTNERS HEALTHCARE FUND V LPJun 2026 · 9 LPs$608.9MAUM

F-PRIME CAPITAL PARTNERS LIFE SCIENCES FUND VII LPJun 2026 · 9 LPs$606.3MAUM

F-PRIME CAPITAL PARTNERS LIFE SCIENCES FUND IX LPJun 2026 · 2 LPs$498.5MAUM

F-PRIME CAPITAL PARTNERS LIFE SCIENCES FUND VIII LPJun 2026 · 9 LPs$463.4MAUM

IMPRESA FUND VJun 2026 · 200 LPs$404.6MAUM

F-PRIME CAPITAL PARTNERS TECH FUND II LPJun 2026 · 9 LPs$358.2MAUM

DI CONSUMER FUND I LPJun 2026 · 2 LPs$352.8MAUM

F-PRIME CAPITAL PARTNERS LIFE SCIENCES FUND VI LPJun 2026 · 9 LPs$294.3MAUM

Source: SEC Form ADV Schedule D and EDGAR Form D filings. AUM is gross asset value as reported by the adviser.

Latest on 𝕏

F-Prime @fprimecapital

Nava Therapeutics is building next-gen lipid nanoparticles to do exactly that — targeting T cells, the kidney, and beyond. Proud to back the team as they emerge with $89M and head toward the clinic. 🧬 https://t.co/IVtAWuXrKC

Jul 15, 2026 · ♥ 3 · ⇄ 2

F-Prime @fprimecapital

AJ Loiacono spent years auditing PBM contracts and found a system obscuring costs rather than lowering them. His conclusion: real change would require rebuilding from within. In 2017, he did exactly that. Now @judihealth covers 58M+ lives. Full Q&A👉https://t.co/VyLpJohFgn

Jun 25, 2026 · ♥ 3

F-Prime @fprimecapital

F-Prime is honored to be named as a top investor for #GenAI & #mentalhealth in Galen Growth's 2024 report of the Health Tech 50 Core Investors. #HealthTech 50 report provides a deep dive into the top investors revolutionizing the digital health landscape: https://t.co/z2eNHLwEPf https://t.co/ObB1DmQaYp

Feb 6, 2025 · ♥ 9